Associate Professor, Radiation Oncology, Surgery, Orthopaedic Surgery & Graduate School of Biomedical Sciences
Education – MD, University of Missouri-Kansas City, Kansas City, MO, 2008
Preliminary Internship in Medicine, Saint Louis University Hospitals, Saint Louis, MO (2008-2009)
Residency, Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI (2009-2013)
Radiation Oncology, American Board of Radiology (2014)
Patient Care Emphases
Yolanda Bryce, MD, RPVI completed her Medical School training at Loma Linda University School of Medicine in 2009, followed by a Diagnostic Radiology Residency at Mount Auburn Hospital in Cambridge, Massachusetts in 2014, a subspecialty training in Breast Imaging at Memorial Sloan Kettering Cancer Center (MSKCC) in 2015, and a Fellowship in Vascular and Interventional Radiology at Miami Cardiac and Vascular Institute in 2016.
She joined the faculty at Memorial Sloan Kettering Cancer Center in August 2016 where she probes the intersection of her subspecialties, pioneering minimally invasive cryoablation technique to treat locoregional disease in patients that are poor surgical candidates or refuse surgery. She serves as her institution’s co-Principal Investigator (PI) for a multi-institutional trial that evaluates the outcome of combining cryoablation and immunotherapy in breast cancer and will serve as PI for a new trial evaluating immune response in cryoablation and metastatic triple negative breast cancer.
She also specializes in vascular disease in oncologic patients, boarded through the American Board of Vascular Medicine and holding a Registered Physician Vascular Interpretation (RPVI) certification. In 2018, she became the founding director of MSKCC’s Noninvasive Vascular Imaging Center and started the institution’s Peripheral Arterial Disease (PAD) program improving mobility and quality of life of some of the most vulnerable patients – those with both cancer and life-limiting PAD. Her new trial will examine the benefit of screening for PAD in at-risk cancer patients. She is also program director of the Interventional Radiology Residency and Interventional Oncology Fellowship programs at MSKCC, revamping their infrastructure and vision.
Dr. Antonio Ucar is a medical oncologist at the Miami Cancer Institute, part of Baptist Health South Florida and has over 35 years of experience in the field of medicine. He is the Principal Investigator of several clinical trials in gastrointestinal cancers at the Miami Cancer Institute.
He received his medical degree from the University of Panama School of Medicine. Dr Ucar completed internal medicine residency and hematology and oncology fellowships at the University of Miami/Jackson Memorial Hospital and is certified in Medical Oncology and Hematology by the ABIM. He is the chair of the gastrointestinal cancers disease management team at the Miami Cancer Institute.
Dr. Siddharth Padia is an Interventional Radiologist and Professor of Radiology at the David Geffen School of Medicine at UCLA. He is also director of Interventional Radiology at UCLA Santa Monica. His areas of clinical expertise and research interests include liver cancer, interventional oncology, vascular disease and portal hypertension.
Dr. Padia earned his medical degree from Johns Hopkins University School of Medicine. After completing his transitional internship at The University of Hawaii in Honolulu, Dr. Padia began his residency in diagnostic radiology at the Cleveland Clinic in Ohio and graduated as Chief Resident. After spending many years practicing interventional radiology at the University of Washington, Dr. Padia joined the faculty at UCLA in 2016.
Dr. Padia specializes in advanced minimally-invasive technologies to treat liver cancer by infusing highly radioactive particles (Yttrium-90) into the liver, and has treated over 800 patients with this therapy. Due to his expertise in this field, he is the primary author of the national treatment guidelines for Yttrium 90 radioembolization, and is a director of the national annual course to educate physicians on this therapy. Recently, he has helped develop novel treatments for patients suffering from knee arthritis, specifically genicular artery embolization. He has recently led and completed the largest US clinical trial to date for genicular artery embolization, and is embarking on multiple trials for embolization of joint pain.
Rupesh Kotecha, M.D., is a board-certified radiation oncologist and Chief of Radiosurgery in the Department of Radiation Oncology and Director of the Central Nervous System (CNS) Metastasis program at Miami Cancer Institute. He is an associate professor in the departments of radiation oncology and translational medicine at the FIU Herbert Wertheim College of Medicine.
He has specialized training and experience in utilizing the latest techniques in radiation therapy for both cancer and noncancerous conditions. His research background and clinical interests have primarily focused on the treatment of patients with stereotactic radiotherapy, including CyberKnife, LINAC-based, and GammaKnife radiosurgery, and stereotactic body radiation therapy (SBRT) or stereotactic ablative radiotherapy (SABR). He also specializes in advanced radiation therapy treatment techniques, including re-irradiation, proton beam radiotherapy, and MR-guided radiation therapy.
During medical school, Dr. Kotecha was inducted into the Alpha Omega Alpha Honor Medical Society, an organization that recognizes excellence in scholarship and the profession of medicine. He has been an invited speaker at numerous national and international symposiums, and has published multiple book chapters and over 100 manuscripts in peer-reviewed journals. His research bandwidth spans investigator-initiated studies to multi-center trials to national cooperative group clinical protocols. Dr. Kotecha serves as the CNS co-chair for the Proton Collaborative Group, coordinates the NCI Glioblastoma Clinical Interest Group, and is a course director for the annual Miami Brain Symposium. He is an editorial contributor and advisory board member on the topic of brain cancer for Practice Update, an online resource for healthcare providers throughout the United States and around the world.
Education, Fellowship, & Training
Medical School- Michigan State University College of Human Medicine, East Lansing, Mich.
Residency – Radiation Oncology, Cleveland Clinic, Taussig Cancer Institute, Cleveland, Ohio
Dr. Gandhi did his undergraduate studies at Northwestern University and Harvard University. He graduated summa cum laude (highest honors). He received his degree in medicine from Northwestern University Medical School, where he also graduated with honors. Following medical school, he completed a surgical internship at Cornell University Medical Center and New York Presbyterian Hospital. He completed his residency training and fellowship at UCLA Medical Center. Currently, he is clinical professor at the University of South Florida School of Medicine and FIU Herbert Wertheim College of Medicine. Dr. Gandhi regularly trains other physicians in various vascular/endovascular, interventional radiology, and interventional oncology techniques.
Because of his interest in discovering new therapies, Dr. Gandhi also dedicated an entire year to biomedical research at the renowned Memorial Sloan-Kettering Cancer Center in New York. He also served as a research fellow at the National Institutes of Health (NIH). He has published his findings in several scientific journals and also authored several textbook chapters and presented his research at national and international meetings. Dr. Gandhi is the recipient of multiple awards. He is the co-author of the textbook Interventional Oncology which was recently published. He is a program director for the International Symposium on Endovascular Therapy (ISET) and Symposium on Clinical Interventional Oncology (CIO).
Richard S. Finn, MD
Department of Medicine
Division of Hematology/ Oncology
UCLA David Geffen School of Medicine
Director, Signal Transduction and Therapeutics Program,
Jonsson Comprehensive Cancer Center
University of California, Los Angeles
Dr Finn is a Professor of Clinical Medicine in the Division of Hematology/ Oncology at the UCLA David Geffen School of Medicine and Director of the Signal Transduction Program in the Jonsson Comprehensive Cancer Center at UCLA.
He currently splits his time between patient care and laboratory and clinical research. His research interests lie in the development of molecular targeted agents and biomarkers in liver cancer and breast cancer. Dr Finn has served as principal and sub-investigator in trials exploring the use of targeted therapies in breast and hepatocellular cancers. He has a particular interest in identifying predictive markers of response to novel therapeutics. His work has been published in journals such as the New England Journal of Medicine, The Lancet, Journal of Clinical Oncology, Lancet Oncology, Cancer Research, Clinical Cancer Research, Hepatology, Cancer Cell and elsewhere. Dr Finn has also given oral presentations at major meetings including American Society of Clinical Oncology (ASCO), European Cancer Conference (ECCO/ ESMO), and the American Association of Cancer Research (AACR) and others. An active cancer researcher, he has been involved in the development of several novel therapeutics in cancer medicine. He has brought several practice changing advances to cancer medicine. He played a lead role in the approval of palbociclib (Ibrance), the first CDK 4/6 inhibitor in cancer medicine, from pre-clinical development to global registration and more recently the combination of atezolizumab and bevacizumab for the treatment of advanced liver cancer.
Dr Finn is a member of ASCO, American Association of Cancer Research (AACR) and the European Society of Medical Oncology (ESMO). He is a past president of the International Liver Cancer Association (ILCA). He is on the editorial board of Clinical Cancer Research.
Dr. Bayona Molano is board certified in Diagnostic Radiology and earned her certificate of added qualification (CAQ) in Interventional Radiology from the American Board of Radiology.
Dr Bayona has over 15 years of clinical, teaching and research experience in vascular and interventional radiology. She has worked in UT Southwestern Medical Center in Dallas. Her clinical interest includes Transplant interventions, interventional oncology and portal hypertension. In these areas she has presented many invited lectures and has published her work in reputed journals.
She has been active as an educator and has delivered many invited lecturers at specialty meetings both in the national and international platforms. She is an active member of the SIR and SIO and participates in multiple committees. She also has been participating in multicenter clinical trials. Her interest in education has earned her university professor ships and mentorship awards. She is a featured editor for Journal of Vascular Interventional Radiology and have been participate in other journals like Journal of Cardiac Surgery, Cardiovascular and Interventional Radiology, and Hepatology.
Luis E. Raez, MD, FACP, FCCP; is the President of the Florida Society of Clinical Oncology (FLASCO). He works as Chief Scientific Officer & Medical Director of Memorial Cancer Institute (MCI), he is also Director of the Thoracic Oncology Program.
He is Co-Director of the MCI/FAU Florida Cancer Center of Excellence designated by the Florida governor, one of the 5 centers in Florida. He is also Clinical Professor of Medicine at FIU, Visiting Professor of Medicine at Cayetano Heredia University in Peru and Associate Professor of Clinical Biomedical Science for FAU. He was also faculty at Sylvester Cancer Center/University of Miami for 10 years (2001-2011).
He has expertise in medical oncology in the areas of lung cancer, and head and neck cancer. He designs phase I-III clinical trials with new chemotherapeutic agents and combinations. He has given oral presentations in 5 continents. He is American Board Certified in: Internal Medicine and Medical Oncology. He is board eligible in Hematology.
Jean-Francois (Jeff) H. Geschwind, MD, is currently the Director of Oncology at USA Clinics Group; the Medical Director for Oncology and Image-Guided Therapy at Syntactx/NAMSA, a contract research organization based in New York City; Senior Scientist for Clinical and Scientific Affairs, Imaging Endpoints, LLC, a contract research organization specialized in imaging; and a consultant for Cage Pharma, previously PreScience Labs, a company he founded in 2009 which is focused on developing cancer drugs targeting tumor metabolism, specifically glycolysis. He is also a scientific consultant for Philips Healthcare advising them on all matters related to oncology and image-guided therapy.
Dr. Geschwind earned his Medical Degree from Boston University School of Medicine, completed his residency training in Diagnostic Radiology at the University of California at San Francisco as a Resident-Scholar sponsored by the National Institutes of Health (NIH) and his fellowship training in Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine. He is the former Director of the Division of Vascular and Interventional Radiology at the Johns Hopkins University School of Medicine and Chairman of Radiology and Biomedical Imaging at Yale School of Medicine.
Dr. Geschwind has published almost 300 scientific manuscripts (Google Scholar H-Index 75), wrote the first textbook dedicated to Interventional Oncology, co-edited the textbook of reference in Interventional Radiology, namely, Abram’s Angiography, and was the lead or co-investigator on more than 50 clinical trials testing innovative treatments for patients with liver cancer. Dr. Geschwind is recognized internationally as an expert and key opinion leader in liver cancer.
Dr. Geschwind has received numerous national and international awards throughout his career including among others, the Annual Memorial Award from the Association of University Radiologists, the Alexander Margulis Award for Excellence in Research, the Society of Interventional Radiology Gary Becker Young Investigator Award, the American Society of Clinical Oncology Merit Award, the American Roentgen Ray Society Fellowship Award, the Boston University School of Medicine and the University of California San Francisco Department of Radiology Alumni Award, the Ernest Ring Academic Development Program from the Society of Interventional Radiology and the Wilhelm Conrad Roentgen Honorary Award from the European Society of Radiology. In 2012, he was inducted into the Academy of Radiology Research from the Radiology Society of North America, the highest recognition for radiologists.
Dr. Geschwind was visiting professor and has given numerous lectures and keynote speeches including named lectures at various prestigious institutions such as (among others) the NIH, Memorial Sloan Kettering Cancer Center, University of Pennsylvania, MD Anderson Cancer Center, the University of Michigan, Georgetown University, Brown University, Yonsei University, Seoul National University, Malaysia Cancer Center, and the Chinese University of Hong Kong. Dr. Geschwind has also been recognized as a Top Doctor by US News and World Report.
Dr. Rocha is the Hedinger Chair and Chief of the Division of Surgical Oncology at Oregon Health and Science University (OHSU) in Portland, OR. He also serves as the Physician-in-Chief of the Knight Cancer Institute at OHSU.
He graduated with honors from the University of Chicago Pritzker School of Medicine. After training in general surgery at the Brigham and Women’s Hospital and Harvard Medical School, he completed both a surgical oncology and hepatopancreatobiliary surgery fellowship at Memorial Sloan-Kettering Cancer Center in New York.
Dr. Rocha’s clinical practice encompasses all aspects of benign and malignant disease of the liver, bile ducts and pancreas. He has been funded by the AAS, NIH/NIDDK, ASCO and the Cholangiocarcinoma Foundation. Dr. Rocha currently sits on the editorial boards of HPB, Annals of Surgical Oncology, Journal of Surgical Oncology and PLoS ONE. He has served on the NCI Pancreas Task Force, ASCO Gastrointestinal Cancers Advisory Council and ASTRO Liver Cancer Guidelines Committee. He is currently the surgical lead of the International Cholangiocarcinoma Research Network (ICRN) and Vice-Chair of the Southwest Oncology Group (SWOG) Surgery Committee.
Caio Max S. Rocha Lima, M.D. is the M. Robert Cooper Professor in Medical Oncology. He is the Co-leader GI Oncology and Co-leader Phase I Programs at the Division of Hematology and Oncology at Wake Forest School of Medicine in Winston-Salem, NC. Prior to join Wake Forest School of Medicine, Dr. Rocha Lima was the Associate Cancer Center Director for Translational Research Gibbs Cancer Center & Research Institute and CMO Guardian Research Network Dr. Rocha Lima received his medical degree from the Federal University of Bahia-Salvador and later pursued residency training at the Clinical Hospital of Sao Paulo University; both in his native country of Brazil.
Afterwards Dr. Rocha Lima completed a fellowship in hematology/oncology at the Medical University of South Carolina. Dr. Rocha Lima was an assistant Professor of Medicine at Moffitt Cancer Center in Tampa, Fl. As a full Professor, at the University of Miami, he was the Program Co-Leader for Pancreatic/Hepatobiliary and Colorectal Cancer Site Disease Groups. He also co-lead the Phase I program at the University of Miami. Dr. Rocha Lima’s professional memberships include the American Society of Hematology, The American Society of Clinical Oncology, the East Cooperative Oncology Group, and the European Society of Medical Oncology, where he served as the USA ASCO representative in 2002-2003.
Dr. Rocha Lima has engaged in a considerable number of studies that investigate the use of novel agents to treat solid tumors, including pancreatic cancer, lung cancer, and colorectal cancers. He was frequently involved as a principal or co-investigator in many clinical trials including the PI of a phase III trial that involved the Americas, Asia and Australia in Pancreas cancer. Dr. Rocha Lima’s research has been widely published in journals such as Journal of Clinical Oncology, Chest, Oncology, Seminars in Oncology, Cancer, and The Annals of Oncology.
Dr. Prologo is an interventional radiologist whose research has focused on the application of image guided techniques to the delivery of stem cell therapies, the treatment of pain, and for management of complex metabolic conditions – specifically through integration of interventional cryoneurolysis procedures to patient care algorithms. He is an Associate Professor in the Department of Radiology and Imaging Sciences at Emory University in Atlanta, GA – and is the author of The Catching Point Transformation: A Twelve Week Weight Loss Strategy Based in Reality.
Alan Alper Sag, MD is currently Assistant Professor of Radiology at Duke University School of Medicine and Interventional Radiologist at Duke University Medical Center. He is a member of the Duke Orthopedic Oncology Bone Metastasis Clinic and Duke Cancer Institute Spine Metastasis Clinic.
He specializes in treatments for metastatic bone tumors using CT-guided cryoablation and angiography with embolization, as well as stabilization of pathologic fractures via kyphoplasty, vertebroplasty, sacroplasty, and acetabuloplasty. He also specializes in treatment of cancer pain using nerve blocks and cryoneurolysis. He is a member of the Duke Endocrine Neoplasia Team and founder of the Duke Thyroid RFA Clinic, with emphasis on benign thyroid nodule RFA, goiter embolization and cryoablation of locally recurrent thyroid cancer.
American Board of Radiology, Interventional and Diagnostic Radiology
Interventional Radiology, Memorial Sloan Kettering Cancer Center (New York), 2014
Interventional Radiology, New York-Presbyterian/Weill Cornell Medical Center, 2014
Radiology, Beaumont Health (Michigan), 2013
As an academic faculty member at Duke University School of Medicine, I hold over forty publications and have lectured and written chapters on bone tumor treatments, cancer pain, and thyroid nodules.
Dr Uthappa has been a consultant interventional radiologist for 5 years in UK and for the past 13 years in Bangalore. He has performed over 18,500 procedures in the last 20 years.
He has performed various vascular interventions (Angiograms, Angioplasty, Venoplasty, Vascular stenting), Hepatobiliary interventions (Chemoembolization and Radioembolization for liver tumors, embolization in hepatic arterial and venous injury, RF ablation for liver tumors, Biliary drainage and stenting, Hepatic vein stenting, TIPSS), GI interventions (mesenteric angiograms, SMA stenting, Embolization for various forms of GI bleeding, Esophageal dilatation and stenting), Urology interventions (nephrostomy, ureteric stenting, Varicocele embolization), Gynecology procedures (Fallopian tube recanalization, Uterine fibroid embolization, Ovarian vein embolization, embolization procedures in high risk pregnancy), embolization of vascular malformations, Varicose vein ablation procedures, RF ablation for Palliation in various forms of cancers and Central venous access for dialysis and chemotherapy. In the last one year he has performed the first case prostate artery embolization and microwave ablation for liver cancer in south India.
Fellowship & Membership
• KMC, India
• GMC, UK
• RSNA, USA
• CIRSE, Europe
• IRIA, India
• ISVIR, India
Awards & Achievements
• PM award for best cadet in NCC, 1987
• Gold medal in Medical College, 1993
• First to start Raioembolisation (TARE) for advanced liver cancer in south India, 2008
• First to start Microwave ablation for liver cancer in south India, 2016
• First to start Prostate Artery Embolization in south India, 2016
• First to set up a dedicated department of Interventional Radiology and interventional Oncology (IRIO) in Private Hospitals. India, 2011
• Started an educational CME for radiology students called GIRS (global interventional radiology symposium), 2013
• First to start Interventional Radiology training in private hospitals in Bangalore and Chennai, 2011
Field of Expertise
• Hepatobiliary and GI interventions
• Interventional Oncology
• Uterine Fibroid embolization (UFE)
• Prostate artery embolization (PAE)
Arvin George, MD is a Urologic Surgeon specializing in the diagnosis and management of genitourinary cancers. After obtaining his medical degree from the Royal College of Surgeons in Ireland, he completed his Urology Residency at the Smith Institute for Urology, Hofstra North Shore-LIJ School of Medicine. He remained to complete his Endourology fellowship in New York gaining additional subspecialty expertise in robotic, laparoscopic, and percutaneous surgery. Subsequently, he completed a Urologic Oncology fellowship at the National Cancer Institute, National Institutes of Health. Dr. George’s clinical practice includes both surgical and non-operative management of prostate, kidney, ureteral, testicular, and bladder cancers. Dr. George’s research interests include minimally invasive and image-guided treatments, functional prostate imaging and focal therapy for prostate cancer.
Areas of Interest
Dr. George’s research focuses on the use of prostate MRI, MR/Ultrasound fusion-guided prostate biopsy, and focal therapy for prostate cancer. His research aims to identify appropriate use for imaging in diagnosis, risk stratification, and management of prostate cancer including active surveillance and selection/treatment of patients with novel focal therapy modalities.
Prostate Cancer (Robotic Prostatectomy, Focal Therapy), Kidney Cancer (Robotic/Laparoscopic, Open surgery), Bladder Cancer, Testis Cancer.
Royal College of Surgeons in Ireland, 2007
Hofstra North Shore-LIJ School of Medicine, General Surgery, NY, 2008
Hofstra North Shore-LIJ School of Medicine, Urology, NY, 2012
Endourology, The Smith Insitute for Urology, Hofstra-North Shore LIJ School of Medicine, 2013
Urologic Oncology, National Cancer Institute, National Institutes of Health, 2016
American Urological Association
Society of Urologic Oncology
American College of Surgeons
Dr. Deepa Shree is a MRCP FRCR CCT (UK) & European board certified in Interventional Radiology. She heads the dept of interventional radiology at Dr Rela institute and medical centre. She is also the Interventional Radiology Fellowship Program Director. Apart from her core expertise, Dr. Deepa is immensely passionate about helping others with mental wellbeing & holistic health. Now she adores not just this zeal, but also the right credentials, life-tested experience along with happy testimonials that followed from those who benefited. Dr. Deepa is a Certified psychologist & belief clearing practitioner. She is also a Zumba instructor helping people with their fitness goals. Determined to do more, Dr. Deepa ventured into writing through her debut book “Art of balance”.
She is also a Motivational Speaker, with experience in delivering workshops, development training to the Big5’s & MNCs. She has a devoted following on social media platforms, many of whom actively seek Dr’s guidance, motivation, or wisdom in different walks of life. Dr. Deepa wanted to take this further to help more people. Thus, was born her new book “Magnetic Of Mind” which is launching soon on Amazon Kindle platforms. The book is an easy-to-use guide about the positive & negative poles within each of us. It is an attempt to kindle inspiration to explore these poles, so that one can engineer one’s life as desired. Packed with research, life stories, personal experiences & even mistakes to learn from, the author feels the book could be a life-changing read. Hope the book helps you have your poles controlled your way towards bliss & beyond. Happy reading.
More feathers to Dr. Deepa’s hat –
Dr. Bhavesh Thakkar
MBBS, MD (Medicine), DNB (Gastro) – Gold Medalist
Practising Since : 2009
Dr. Bhavesh Thakkar is a proficient Gastroenterologist from Ahmedabad spearheading the Department of Gastroenterology at CIMS Hospital as HOD. Apart from this, Dr. Thakkar is also a visiting Gastroenterologist at Gujarat Cancer Research Institute, Ahmedabad since Jan 2014.
Dr. Thakkar, an alumnus of Govt M P Shah Medical College (Jamnagar), has completed post graduation in MD (Medicine). Furthermore, Dr. Thakkar finalized DNB (Gastroenterology) from Apollo Hospital, Chennai during… [+]
Thesis work: “Endoscopic ultrasound guided FNAC and cystic fluid analysis for pancreatic and peripancreatic mass lesions” A study of 50 cases.
Teaching experience as Assistant Professor, Department of Medicine, MP Shah Medical College, Jamnagar.
Dr. Nitin Shetty is a radiologist in Mumbai, Maharashtra, India. Dr. Nitin Shetty is affiliated with Tata Memorial Hospital, Mumbai. Dr. Nitin Shetty provides diagnosis of various diseases using imaging modalities like X- rays, CT scan, MRI etc. Here you can find contact information like phone number and reviews for Dr. Nitin Shetty.
A radiologist is a medical professional who has been trained to diagnose injuries and diseases with the use of x-rays. Radiologists can diagnose a variety of different diseases and injuries. They can also determine the severity of the problem through imaging scans.
Tata Memorial Hospital, Mumbai
Consultant radiologist at Tata Memorial Hospital with special interest in Breast, Gynaecological and Urological malignancies.
Palak Bhavesh Thakkar – Palak Popat
Associate Professor & Consultant
Department of Radiodiagnosis
Tata Memorial Centre
Tata Memorial Centre Advanced Centre for Treatment, Research and Education in Cancer
2013 has seen the institution expand its activities outside its traditional bastion of Mumbai with projects at Vizag, Chandigarh, Sangrur, in addition to the cancer registries that are being setup all over the country. This notwithstanding, there has been a lot of activity at Parel as well, towards our mission of providing the best cancer care to all who seek treatment at the hospital. We are constantly mindful of the fact that the existing infrastructure at the hospital is stretched given the patient load. The majority of our efforts and initiatives are therefore directed at being patient friendly.Towards these goals we augmented our semiprivate bed strength where wait lists were over 6- 8 weeks by converting the old private wards in the main building to semi private accommodation. The private rooms are now exclusively housed in the new Homi Bhabha block. This helps in accommodating more patients while maintain the 60:40 general to private ratio. Our smart card transactions have now been expanded to cover the inpatient services and the general category patients as well. The smart card ensures that all services at the hospital are now cashless, saving time patients spent in long queues. In addition, smart card kiosks are setup all over the outpatient areas to help patients to check balances, expenditures, deposits as well as status of their reports. Patients now also get SMS alerts of their smart card transactions. Towards a green environment our paperless operations have been expanded with no printing of patient reports and pharmacy memos. Patients can however view and prints reports at any time from any location as these are available on the web with restricted access only to the patient and his / her treating clinician.Infrastructure has been augmented with the installation of high value equipment that includes a digital mammography, augmentation of the minimal invasive surgical capabilities, surgical microscopes and anesthesia delivery systems.There has been a major revamp of the hospital Institutional Review Board with space allocated for a dedicated trial pharmacy. In addition, our pediatric ward and outpatient clinic have had a major revamp through a generous philanthropic gesture, making it more child friendly for our young patients. Our service to the Rajiv Gandhi Jeevan Arogya Yojana for patients below the poverty line initiated by Government of Maharashtra has been well appreciated, with the hospital recognized as the leader in the care of cancer patients under this scheme.A financial management system with the help of the ECIL is also fully implemented putting inplace greater accountability and ease in our accounting process. These efforts are reflected in the fact that we have won the best Oncology hospital award by CNBC – ICICI Lombard for the 4th year in running. I place on record the contribution of each and every one of our staff who many a time, work well beyond the call of normal duty.
Cutaneous (skin) Cancer Surgery
Chief of Melanoma & Soft Tissue Sarcoma Surgery
Education and Training
American Board of Surgery, 2002
Miami Cancer Institute Names Ramon Jimenez, M.D., FACS, Chief of the Division of Melanoma and Soft Tissue Sarcomas
MIAMI, FL – October 9, 2017 – Surgical oncologist Ramon Jimenez, M.D., FACS, has joined the world-class team of specialists at Miami Cancer Institute at Baptist Health South Florida, the region’s premier cancer treatment and research destination. Dr. Jimenez will serve as chief of melanoma and soft tissue sarcoma surgery. Highly experienced in utilizing innovative surgical techniques to treat a wide variety of cancers requiring surgical intervention, he specializes in the surgical treatment of melanoma and soft tissue sarcomas — the latter referring to rare cancers that start in the soft tissues of the body, such as fat and muscle.
In practice for more than 20 years, Dr. Jimenez will collaborate with the Institute’s multidisciplinary teams of cancer care specialists, including pathologists, medical oncologists, radiation oncologists and patient support specialists, to provide the most effective treatment plan for each patient.
“Treating rare cancers requires rare skill, and Miami Cancer Institute continues to build an interdisciplinary cancer care team composed of specialists who are experts in their fields,” said Michael J. Zinner, M.D., founding CEO and executive medical director of Miami Cancer Institute. “The appointment of Dr. Jimenez at the Institute is evidence of our commitment to providing each patient with the most advanced, effective cancer care.”
Dr. Jimenez, who is Board-certified in general surgery, received his undergraduate degree in biology from Yale University, graduating summa cum laude, and earned his medical degree at the Johns Hopkins University School of Medicine. He completed a general surgical residency at Massachusetts General Hospital, followed by a fellowship in surgical oncology at Memorial Sloan Kettering Cancer Center. His postdoctoral training also included a surgical research fellowship at Harvard Medical School.
Prior to joining Miami Cancer Institute, Dr. Jimenez was director of the Division of Surgical Oncology at Hartford Healthcare Medical Group in Hartford, Conn. An educator as well, he served as clinical assistant professor of surgery at the University of Connecticut School of Medicine. He has authored numerous peer-reviewed articles and book chapters and has presented abstracts at medical symposiums throughout the U.S. Dr. Jimenez is a Fellow of both the American College of Surgeons and the Society of Surgical Oncology and a member of several professional medical associations.
Professor of Radiology, Sri Ramachandra Medical College Chennai
President IRIA ,TN & PY Chapter 2013 -14
Senior consultant, Department of Radiology Sri Ramachandra Medical centre and Santosham Chest Hospital Chennai.
MBBS from Stanley Medical College Chennai
DMRD from Madurai Medical college Madurai
Post Graduate Masters degree from Madras Medical College Chennai.
Founder Chairman of Indian Academy of CT interventions.
Founder President SIO ( Society ot interventional oncoradiology ) India
Chairmen: Board of Directors ASTA ( Asian Society of Tumour ablation )
Delivered Invited Guest lecturers in
CIRSE ( Cadiovascular and Interventional society of Europe ) 2011 in Munich.
ECIO 2012(European Congress of Interventional Oncology) in Florance.
SYNERGY 2012 (Conference in Multidisciplinary Oncology – Conducted by University of Miami .
ACTA 2017 ( Guangzhou ) China
Delivered Professor Arthur Daniel Memorial Oration in IRIA TN & PY state congress 2012 at Coimbatore.
Invited to write an article “When Robots take over ” in CIRSI( Cadiovascular and Interventional society of Europe ) in 2011. news paper
Co Inventor of PIGA CT (winner of Frost & Sullivan 2009 Product Innovation Award)
Joint holder of US patent for PIGA CT with Perfint Health care corporation.
Inventor of HigHNoon: India’s first Non-Robotic CT Navigation Device.( Gold medal winner Medicall 2017 – Best medical innovation award. )
Founder/ Director Kornerstone Devices Pvt Ltd.
Organizing chairman : ACTA 18 Chennai ( Asian Conference on tumor Ablation )
First to perform Percutaneous Radiofrequency Ablation ( RFA )to treat tumors in the country.
30 publications in peer reviewed journels.
Conducts regular Vertebroplasty & CT guided non – vascular intervention Hands on Cadaver courses in India and overseas.
MBBS, MD – Radio Diagnosis/Radiology
26 Years Experience Overall (21 years as specialist)
Medical Registration Verified
Dr. Aniruddha Kulkarni is a Radiologist and has an experience of 26 years in this field. He completed MBBS from Government Medical College, Aurangabad Maharashtra in 1995 and MD – Radio Diagnosis/Radiology from Government Medical College, Aurangabad Maharashtra in 1999.
He is a member of Indian Medical Association (IMA),IRIA and Indian Federation of Ultrasound in Medicine and Biology (IFUMB). Some of the services provided by the doctor are: Vascular Imaging,General Radiology and Teleradiology etc.
Dr. Chapiro joined the Department of Radiology and Biomedical Imaging as a research scientist and interventional radiology resident from Berlin, Germany. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen with summa cum laude, he served as a postdoctoral research fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin.
Dr. Chapiro’s research focuses on developing new quantitative imaging biomarkers for the diagnosis, characterization, and therapeutic management of liver cancer. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence solutions for the management of liver cancer. His basic research interest mainly focuses on developing new tools to characterize the tumor microenvironment and the immune system in the setting of loco-regional, image-guided therapies of liver cancer.
innovative and clinically applicable imaging solutions for liver cancer with advanced molecular imaging, image post-processing and machine learning approaches and translating them to clinical practice has been his central mission for the past decade. He authored and co-authored >100 original research articles, reviews and book chapters and gave more than 70 talks and invited lectures within the last five years. His research has also resulted in several patents, 510(k)-approved medical products and significant grant support from federal, foundational and industry sources. He is an active research mentor to more than 30 undergraduate, medical and graduate students as well as peers both at Yale and other national and international institutions. Being an active contributor, journal-, abstract- and grant reviewer in several professional societies (RSNA, SIR and SIO), he is also committed to education and the mission of disseminating research data and scientific knowledge. Dr. Chapiro consults the Editorial Board of the Journal of Hepatology, is a member of the American College of Radiology Liver Imaging Reporting and Data System (LI-RADS) Steering Committee, he additionally serves on the Society of Interventional Oncology Research Committee and is the incoming Chair of the Annual Meeting Program Planning Committee for the Subspecialty of Interventional Radiology at the Annual Radiological Society of North America meeting 2021-2023. He is the co-initiator of the “Rising Star” Student Exchange Program in collaboration with the Charité University Hospital in Berlin and co-directs the Yale Interventional Oncology Research Laboratory. Dr. Chapiro is the Associate Director of the Clinical and Translational Core of the Yale Liver Center.
Education & Training
University of Leipzig (2012)
Departments & Organizations
Dr. Wael Saad is a senior vascular and interventional radiologist.
Dr. Saad received an MD from the Egypt-Cairo University of Faculty Medicine, and he completed a transitional internship at Ain Shams University Hospital of Cairo. He completed residency training in Diagnostic Radiology at the University of Rochester, where he served as Chief Resident.
In 2004, he completed a fellowship in Interventional Radiology at Washington University, Mallinckrodt Institute of Radiology.
Before joining NIH, Dr. Saad was an Assistant Professor of Radiology and Surgery at the University of Rochester. He obtained a secondary Assistant Professorship of Biomedical Engineering from UR and then earned a promotion to Associate Professor of Biomedical Engineering. In 2007, the University of Rochester appointed him to the Directorship of the Clinical Research Division of Vascular & Interventional Radiology.
In 2009, he joined the University of Virginia as the Director of their Vascular and Interventional Radiology Fellowship program. In 2013, he joined The University of Michigan as Professor and Director of Vascular & Interventional Radiology (IR).
He joined the Radiology department at NIH in December 2018.
Hepatobiliary and Pancreatic Surgery
Domenech Asbun, M.D., is a hepatobiliary, pancreas and foregut surgeon at Miami Cancer Institute. Dr. Domenech Asbun specializes in minimally invasive surgical procedures to treat liver, pancreatic and upper gastrointestinal diseases. Dr. Domenech Asbun is fluent in English and Spanish and conversational in Italian and Portuguese. Prior to joining Miami Cancer Institute in 2021, Dr. Domenech Asbun completed a fellowship in minimally invasive hepatopancreatobiliary and foregut surgery at the Mayo Clinic Hospital Florida. He has presented at national and international surgical meetings. His research has been published in multiple high-impact surgical journals, including Annals of Surgery and Surgical Endoscopy. He has a strong interest and significant experience in surgical simulation. Dr. Domenech Asbun is passionate about surgery, from the technical aspects to the fulfillment of seeing a patient cured of their complex illness by an operation. His approach to patient care is to treat each patient as a family member when making treatment recommendations. He believes every person deserves high-quality care. When he is not treating patients, Dr. Domenech Asbun enjoys surfing, traveling, photography and reading.
Fellowship Program, Minimally Invasive Surgery, 2021
University of California San Francisco – Fresno
Residency Program, Surgery, General, 2020
Kern Medical Center Program
Residency Program, Surgery, General, 2018
Ross University School of Medicine
Medical School, MD, 2014
American Board of Surgery, 2021
Prof. Luigi Alessandro Solbiati is a Professor of Radiology at Humanitas University (Rozzano – Milan) and Consultant of Interventional Radiology at Humanitas Research Hospital.
In his academic career, since 1988, he has been appointed as Contract Professor of “Techniques and Methods of Diagnostic Imaging” at the School of Radiology of the University of Milan. Previously, in his clinical activity, he worked at the General Hospital of Busto Arsizio (Milan area) as Chairman of the Department of Oncology and Head of the Division of Interventional Oncologic Radiology.
His main fields of interest have always been interventional procedures in oncologic diseases (particularly percutaneous image-guided thermal ablation), imaging of the neck and contrast-enhanced sonography. He was one of the pioneers of ultrasound-guided aspiration biopsies (1979), ethanol injection (1983), radiofrequency ablation with cool-tip electrodes (1995) and microwaves (2009) of solid tumors and fusion imaging for the guidance of interventional procedures (2003).
With his team he has one of the largest experiences in the world in the treatment of liver malignancies with radiofrequency ablation (RFA) and, more recently, high-power microwaves, accounting for more than 2,200 patients, with technical success rates above 90% and major complication rates of less than 1%. These very favorable results have been achieved also thanks to a continuous search of technological advancements of the imaging methods for the guidance of thermal ablations and, particularly, the systems of navigation through the real-time fusion of ultrasound and CT, MRI or, more recently, PET scans.
Prof. Solbiati published 112 original articles in peer-reviewed journals as of yet http://www.ncbi.nlm.nih.gov/pubmed?term=solbiatiL
His H-index is currently 41, his impact factor exceeds 400 and his publications had more than 10,800 citations. He holds the 2nd place in the world ranking of the Authors of the 100 papers of international radiological literature published between 1945 and 2012 with the largest number of citations (Am J
Roentgenol 2013; 201: 471-481)
In addition, he published 81 chapters in textbooks of Radiology, Interventional Radiology and Oncology and was Editor of 11 books on small-parts sonography, contrast-enhanced sonography and ablative therapies.
He gave more than 480 presentations at Meetings in 23 different countries and was Guest Lecturer at the Universities of San Diego, Zurich, Beijing, Hong Kong, New Delhi, Cairo and Vienna and at the Mayo Clinic, Rochester
Activities in Scientific Societies
Dr. Jack Jennings is a Professor in the Department of Radiology and Orthopaedic Surgery at Washington University’s Mallinckrodt Institute of Radiology and serves as the Chief of Musculoskeletal Radiology and Director of Musculoskeletal and Spine Intervention.
Dr. Jennings has co-authored over 80 peer-reviewed journal articles, review articles, and book chapters. He is an active manuscript reviewer for such journals as Radiology, American Journal of Radiology, Skeletal Radiology, Journal of Vascular Interventional Radiology, American Journal of Neuroradiology and Cardiovascular and Interventional Radiology. He has done over 100 invited lectureships with the majority focusing on musculoskeletal and spine tumor ablation. He co-created the multi-disciplinary metastatic spine disease working group in Dallas 2014 composed of recognized experts in the fields of medical, radiation, and surgical oncology and interventional radiology which led to the published algorithms and recommendations for the treatment of metastatic spine disease, including percutaneous tumor ablation.
Dr. Jennings has presented at several national and international radiology and musculoskeletal/orthopedic society meetings, including ASSR, ASNR, ISS, SSR, RSNA, SIO, WFITN, ECIO, WOA, CIRSE, and APSCVIR. He is an active member in these societies including serving on Executive, Program, Clinical Practice, Nominating and Informatics Committees. Dr. Jennings main research interest lies in musculoskeletal and spine tumor ablation, bone and soft tissue biopsies, and osteoporotic and pathologic fracture treatment. He has been involved in multiple funded prospective studies and has been both the institutional and overall Principal Investigator on bone and spine tumor ablation trials. In addition, he has numerous scientific abstracts and presentations at national and international society meetings. Locally, he is actively involved in many multi-disciplinary tumor boards and hospital committees. Dr. Jennings is involved in many active therapeutic trials and has a long-term collaboration with medical, surgical, and radiation oncologists obtaining high quality bone and soft tissue biopsies to meet study requirements.
Primary Academic Title
Professor of Radiology, Division of Diagnostic Radiology, Section of Musculoskeletal Radiology, Washington University School of Medicine
Musculoskeletal Radiology, radiology
Intervention Oncology: Tumor ablation of bone and soft tissue tumors; oncology pain management; bone and soft tissue biopsies, vertebral augmentation and spine tumor ablation.
⦁ 2002: MD, University of South Florida, Tampa
⦁ 1999: PhD, anatomy, University of South Florida
⦁ 2002 – 2003: Intern, internal medicine, University of South Florida, Tampa
⦁ 2003 – 2007: Resident, radiology, Washington University, St. Louis
⦁ 2007 – 2008: Fellow, musculoskeletal radiology, Washington University
⦁ 2007: American Board of Radiology, Diagnostic Radiology
Malagari Katerina graduated from Athens Medical School, National and Kapodistrian University of Athens and got radiology boards in 1990. She had a fellowship in Chest in USA, Birmingham Alabama, and then a second 2-year fellowship in Interventional Radiology in the Dpt of Radiology of the University of Athens. She got her PhD in 1992 and EBIR in 2010. She was a President of ESTI in 2007. She is a member of the editorial board in 5 international journals and got prizes for the “best published study of the year” on five occasions. She was in the team that first introduced EVAR in Greece, and later she focused on interventional oncology. She was awarded the title of distinguished fellow of CIRSE in 2015. She has written 11 greek books and 5 international books. Since 2007 her research work focuses in Interventional Radiology, Chest and Interventional Oncology. She has written 30 articles on chemoembolization and bland embolization of liver tumors, 3 on prostatic embolization, 8 on non vascular liver interventions, 3 on pharmacokinetics, 1 animal study, 16 on chest interventions, 3 on EVAR, and 34 in diagnostic radiology (a total of 98 papers in scopus with an author index 27 and 3.261 citations – 3.162 without self citations. She has 30 publications in greek journals, supervised 46 postgraduate MSCs, 9 PhDs, participated in 9 multicenter project with other European countries and USA. She has a proliferate didactic activity with 103 invited lectures in Greece and 114 lectures in international congresses.
Department of Diagnostic Radiology and Nuclear Medicine, Rush Medical College
Director, Vascular and Interventional Radiology
MD, Marmara University School of Medicine, Turkey
Interventional Radiology and Diagnostic Radiology
Bulent Arslan, MD, is trained for his fellowship at University of Rochester, New York. His first job was at Tucson Veterans Hospital, where he developed a vascular intervention consult service and provided system wide education for management peripheral vascular disorders. Performed first carotid stenting and percutaneous thoracic aneurysm repair in the VA Healthcare system. Received several gold star awards for outstanding service. He then moved to University of Virginia where he performed several first in man procedures, such as in-vivo fenestration of a stent-graft to preserve renal artery flow and percutaneous treatment of bilateral iliac and aortic aneurysm with two bifurcated stent-grafts. He was one of the early adaptors of thoracic Type B Dissection Treatment with Stent-Grafts as part of UVA vascular intervention team led by Dr Dake. His next appointment was Moffitt Cancer Center. Dr. Arslan initiated the radioembolization program at Moffitt. In 2011, 256 radioembolizations were performed which was the highest number of cases in the world. He then moved to Rush University Medical Center in Jan 2012, as the director of vascular/interventional radiology. He started developing both interventional oncology and peripheral vascular and aortic intervention programs at Rush. Radioembolization volume increased 10 folds and critical limb ischemia intervention volume increased 5 folds in the first two years of his tenure at Rush. Almost 1000 CLI interventions performed with 98% technical success rate. He also treats thoraco-abdominal aneurysms with percutaneous approach using Octopus technique. Dr Arslan performed the first ever percutaneous femoral to femoral vein bypass graft procedure to alleviate severe lower extremity swelling with excellent clinical outcome. He also performed the first ever percutaneous ilio-femoral arterial bypass procedure. An active researcher, Dr. Arslan has participated in more than 30 clinical trials and has authored more than 100 peer-reviewed articles and abstracts, as well as several book chapters.
Bulent Arslan, M.D., earned his medical degree at Marmara University in Istanbul, Turkey. He completed a residency in diagnostic radiology and a fellowship in vascular and interventional radiology at University of Rochester Medical Center, NY. Before joining Rush in 2012, he served as Associate Professor of Radiology & Interdisciplinary Oncology at University of South Florida College of Medicine, Tampa. Previously, he served as Assistant Professor of Radiology at University of Virginia Health System, Charlottesville, and at University of Arizona, Tucson. He recently obtained his professorship in Diagnostic Radiology and Nuclear Medicine at Rush University Medical Center Dr Arslan is certified by the ABR in Diagnostic Radiology with CAQ in Vascular & Interventional Radiology. His clinical interests include aortic and peripheral vascular interventions, endovascular treatment of complex abdominal, thoracic, thoracoabdominal and arch pathologies and endovascular tibio-pedal recanalization procedures for critical limb ischemia. An active researcher, Dr. Arslan has participated in more than 20 clinical trials and has authored more than 120 peer-reviewed articles and abstracts, as well as several book chapters. A frequent speaker, he has been an invited lecturer at more than 150 regional, national, and international medical conferences. Dr. Arslan is a fellow of SIR and a member of ARRS, RSNA, CIRSE, NANETS, ISNVD, and AMA. He currently serves as a reviewer for the Journal of Vascular and Interventional Radiology, CardioVascular and Interventional Radiology, and Neurosurgery.
Residency: University of Rochester Medical Center – Diagnostic Radiology
Residency: Haydarpasa Numune Training and Research Hospital – Family Medicine
Fellowship: University of Rochester Medical Center – Vascular & Interventional Radi
Education: Marmara Univ. School of Medicine, Turkey
Academics & Publications
Rush University Medical Center is an academic medical center. In addition to providing patient care, many of our clinicians have faculty appointments at Rush University and perform clinical, basic science and community-based research. Our education and research endeavors are dedicated to enhancing excellence in patient care — now and in the future.
MD, University De Bahia Faculty Medicine – Brazil, 1989
Internal Medicine, Universidade Federal da Bahia, 1989
Internal Medicine, University Sao Paulo Faculty Medicine, 1993
Hematology And Oncology, Medical University of South Carolina, 1998
American Board of Internal Medicine, Internal Medicine
American Board of Internal Medicine, Medical Oncology
Professor, Hematology and Oncology
Assistant Professor of Interventional Radiology, School of Medicine
Special focus on
Before scheduling your appointment, we recommend you contact your insurance company to verify that the OHSU Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any copayments, co–insurance, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with OHSU providers, your out of pocket liability may be higher. Visit the billing and insurance section of our site for more information.
William S. Rilling, MD FSIR is Professor of Radiology and Surgery at the Medical College of Wisconsin. He completed his diagnostic radiology residency at the Medical College of Wisconsin and his Fellowship in Vascular Interventional Radiology at Northwestern University in Chicago in 1996. He has been practicing at the Medical College of Wisconsin since 1996 in the Division of Vascular and Interventional Radiology. Dr. Rilling is also Vice Chair of Clinical Operations in the Department of Radiology.
Dr. Rilling’s areas of interest include image guided therapy of a variety of cancers with an emphasis on liver cancer using chemoembolization, y-90 radioembolization, as well as local ablative strategies such as radiofrequency, microwave and cryoablation. Dr. Rilling has been active in patient care, research, and education in Interventional Oncology for over 15 years. As Education Counselor for the Society of Interventional Radiology, he co-directed the first three meetings to focus solely on IO beginning in 2001.
Dr. Rilling is active in many IO clinical trials and has a strong interest in showing cost effectiveness in IO therapies.
Professor of Radiology & Surgery; Vice Chair, Clinical Operations, Image-Guided Interventions
Vascular and Interventional Radiology
Vascular & Interventional Radiology – Froedtert Hospital
Diseases and Conditions
Treatments and Services
Universidad de Buenos Aires
Ricardo Garcia-Monaco, MD, PhD, FSIR, Chairman of Dep of Radiology, Head of Vascular and Interventional Radiology, Hospital Italiano University of Buenos Aires, Program Director of Interventional and Vascular Radiology of the University of Buenos Aires.
Peer reviewer in several journals, including JVIR and CVIR.
Fellow of the Society of Interventional Radiology (SIR)
Member of RSNA Vascular/Interventional Education Exhibits
Chairman of the RSNA Regional Committee for Latin America of the
International Advisory Committee
Honorary Member of the Radiological Society of North America (RSNA)
Honorary Member of the Societa Italiana de Radiologia Medica (SIRM)
Honorary Member of the European Society of Radiology (ESR)
Honorary Member of the Argentine Society of Radiology (SAR)
Honorary Member of the Societe Francaise de Radiologie (SFR)
Gold Medal of the Argentine Society of Radiology (SAR)
Honorary Lecturer ECIO 2019
462 Scientific or Educational presentations in National or International Congresses.
165 Scientific papers published in national or international journals
Author or coauthor of 37 chapters in different books
Editor or author of 25 books
Matthew R. Callstrom, M.D., Ph.D., is a consultant in the Division of Diagnostic Radiology at Mayo Clinic and a professor of radiology at Mayo Clinic College of Medicine. Dr. Callstrom’s research is centered on interventional oncology.
Significance to patient care
Dr. Callstrom’s research contributes to the development of technologies that will allow better identification and treatment of cancer in the liver, kidney, bone, lung and soft tissue as well as indeterminate lesions in the liver and kidney.
Diagnostic Radiology, Vascular Interventional Radiology, Provider Gender
Radiology Resident, VU Medisch Centrum Academic Medical Center Amsterdam
RFA, Pancreatic Diseases, Radiofrequency Ablation, Computed Tomography, Magnetic Resonance, Biliary Tract Diseases, Liver Diseases, Cholangiocarcinoma, Interventional Radiology, Angiography
Dr. Charles Nutting, DO FSIR is internationally renowned and has been on the forefront of minimally invasive procedures for over 2 decades. He started his career in Arizona before moving to Colorado over 15 years ago. He is internationally known as a physician on the leading edge of minimally invasive treatments and has introduced several procedures and devices to North America. He’s one of the two founders of ECCO after departing from a previous practice where he built his referral and patient base.
Dr. Nutting is a board certified Vascular and Interventional Radiologist with extensive experience in embolization. He specializes in complex treatment for liver cancer and benign prostatic enlargement, which he helped pioneer from their inception. He’s treated more patients with these conditions than anyone else in the entire state of Colorado.
Dr. Nutting was the first interventionalist in the US to perform the game-changing liver cancer therapy, Yttrium-90. He was the first trainer of other physicians for this revolutionary treatment. For years now, he has flown around the country to teach other physicians this intricate procedure. He is a nationally recognized speaker. He has numerous peer-reviewed publications and treats patients from around the world.
Dr. Nutting also brought prostate artery embolization (PAE) to the state of Colorado after training in South America and Europe on the nuances of this complicated procedure. He has done more than anyone in the state and is one of a small number of expert-trainers for this treatment. He has also published several articles on this topic and is a staple on the national speaking circuit.
Dr. Koethe is an interventional radiologist at the Oregon Health & Science University. She treats a diversity of medical conditions, including cancer (including hepatocellular carcinoma/liver cancer, liver metastasis, kidney cancer, pancreatic cancer), uterine fibroids (uterine artery embolization), benign prostatic hyperplasia (prostatic artery embolization), peripheral arterial disease (PAD) and knee arthritis (genicular artery embolization).
Dr. Koethe graduated summa cum laude (highest honor) from Tufts University. She obtained her medical degree from Duke University. Following medical school, she completed an internship at Santa Clara Valley Medical Center. She did her her residency in Diagnostic Radiology at the University of California, San Francisco. Following residency, she further subspecialized in Vascular and Interventional Radiology at the Miami Cardiac & Vascular Institute, a world-renowned center for diagnosis, management and treatment of vascular disease. Currently, she is an assistant professor at OHSU, where she trains other physicians in interventional radiology and interventional oncology techniques.
Dr. Koethe firmly believes in providing individualized, highest quality care for each of her patients. Her clinical interests include women’s health, men’s health, arthritic pain management, and minimally invasive cancer therapies.
She has also served on numerous national and international society committees and scientific journals. She is an active clinical researcher in interventional radiology with over 30 scientific presentations and publications, including her investigation in navigational systems for image-guided ablations at the National Institute of Health.
Dr. Johnson has practiced and instructed interventional radiology since 1992. In his practice, he treats many patients with liver cancer using a wide variety of techniques including radioembolization, chemoembolization, radio frequency and microwave ablation. He also treats those with portal hypertension through transjugular portosystemic shunt (TIPS) creation.
Vice Chair, Professor at Medical College of Wisconsin
Vascular and Interventional Radiology
Hospice and Palliative Medicine
Diseases and Conditions
Dr Praveen Peddu is a Consultant Radiologist with a special interest in axial Imaging and hepatobiliary Intervention. His NHS base is King’s College hospital, London. He initially trained as Surgeon and obtained MRCS from Royal College of Surgeons of Edinburgh. He pursued a career in Radiology in London deanery. He completed his radiology training in King’s College hospital and went on to do sub-speciality training in Interventional Radiology. This was followed by a fellowship in Hepatobiliary Radiology at King’s College hospital and was appointed as Consultant in King’s in 2008. Dr Peddu is the clinical lead for HPB imaging since 2018. He reports general axial imaging as well as specialist imaging in post liver transplant and hepatobiliary oncology. He performs complex hepatobiliary interventions and has introduced and developed Nanoknife service.
Dr Peddu is a Honorary Senior Lecturer at King’s College London. He has authored and co-authored peer reviewed papers, book chapters and presented at all European and North American Radiology meetings.
NHS Base (trust)
King’s College Hospital NHS Foundation Trust
Dr. Brian Lally has been practicing Radiation Oncology for 20 years and treats all cancer types, with a focus on prostate cancer and lung cancer. He serves as a co-chair for the Scientific Planning Committee for the American College of Radiation Oncology (ACRO) and was voted to the Board of Challancelors.
He is a strong advocate for his patients and works very closely with them to ensure their well-being from treatment through survivorship.
Recognized by Best Doctors in America 2015, 2016
Anal Cancer, Brain and Spine Tumors, Breast Cancer, Cervical and Endometrial Cancers, External Beam Radiation Therapy, Genitourinary Cancer, Liver Cancer, Lung Cancer, Lymphoma, Melanoma, Mesothelioma, Multiple Myeloma, Non-Small Cell Lung Cancer, Pancreatic Cancer, Prostate Cancer, Rectal Cancer, Sarcoma, Small Cell Lung Cancer, Stereotactic Radiation Therapy (SRT), Thoracic Cancer
Special focus on
Before scheduling your appointment, we recommend you contact your insurance company to verify that the OHSU Health location or provider you plan to visit is included in your network. Your insurance company will also be able to inform you of any copayments, co–insurance, or deductibles that will be your responsibility. If you proceed in scheduling an appointment and your health insurance benefits do not participate with OHSU providers, your out of pocket liability may be higher. Visit the billing and insurance section of our site for more information.
AJ Gunn, M.D. graduated magna cum laude from Brigham Young University in Provo, UT earning a BS in exercise physiology with a minor in sociology. He then returned home to South Dakota to attend medical school at the University of South Dakota. During medical school, he participated in the competitive Howard Hughes Medical Institute – National Institutes of Health Research Scholars Program and was awarded the Donald L. Alcott, M.D. Award for Clinical Promise. He graduated summa cum laude in 2009. He completed his diagnostic radiology residency at the Massachusetts General Hospital of Harvard Medical School in Boston, MA followed by a fellowship in vascular and interventional radiology at the Johns Hopkins Hospital in Baltimore, MD where he served as chief fellow.
Prior to joining the faculty at the University of Alabama at Birmingham, Dr. Gunn worked as an attending interventional radiologist at Washington University School of Medicine in St. Louis. He has written and lectured regarding patient-centered care in radiology and has interests in the clinical aspects of interventional radiology in addition to patient safety and quality of care. Currently, he serves as the Director of the division’s ambulatory clinic. He serves as a reviewer for multiple journals and as a section editor for a national database of teaching files tailored to radiology trainees. Clinically, Dr. Gunn practices the full spectrum of interventional radiology with a special focus on treating cancer through minimally-invasive techniques such as chemoembolization, radioembolization, and ablation. Additionally, he has interest in IVC filter retrievals and treating women with uterine fibroids.
Afshin Gangi, MD, PhD, is professor of interventional radiology and chief of interventional radiology at the University Hospital Strasbourg, in Strasbourg, France. He is also a professor at King’s College in London, and a member of the Interventional Oncology 360 editorial board. At the 2015 Synergy interventional oncology meeting, IO360 spoke with Dr. Gangi about his specific practice interests and his thoughts on the ways that interventional oncology is growing.
Urologic surgeon with expertise in minimally invasive techniques for the treatment of kidney, adrenal, and prostate cancers. Using laparoscopic, robotic, and image-guided therapies, the goal of our team is to provide appropriate curative therapeutic interventions through the organ-sparing approaches of less-invasive surgery. Interested in the application and careful study of techniques such as robotic (da Vinci) prostatectomy, laparoscopic partial nephrectomy, partial adrenalectomy, cryo- and radiofrequency ablation, and MRI-guided prostate interventions using state-of-the-art instrumentation and imaging technology.
MD, Cornell University Medical College
General Surgery – New York Presbyterian Hospital; Urology – New York Presbyterian Hospital
Urologic Oncology – National Cancer Institute
Dr. Rebekah White completed medical school and general surgery residency at Duke University. During residency, she worked for three years in a nucleic acid therapeutics laboratory, which would later become the focus of her research career. After general surgery residency, she completed surgical oncology fellowship at Memorial Sloan-Kettering Cancer Center then returned to Duke as faculty in 2007. While her laboratory research was primarily focused on nucleic acids, she became interested in irreversible electroporation (IRE), both as a clinical therapy for patients with pancreatic cancer but also for its potential to help overcome some of the barriers to delivery of nucleic acid therapeutics to tumors. She was recruited to University of California San Diego (UCSD) in 2016 to continue these research efforts, and her laboratory is studying immune responses to IRE and ways to improve them. Her UCSD time is divided roughly 50/50 between clinical and research activities. Outside of UCSD, she is involved in several surgical organizations, including the Society of University Surgeons (as President-Elect) and the Society of Clinical Surgery (as Treasurer).
Dr. Murugesan Manoharan, M.D., FRACS , is a urologic oncologist and the chief of urologic oncology surgery at Miami Cancer Institute. Dr. Manoharan specializes in the treatment of genitourinary cancers, including bladder, kidney, prostate and testicular cancer. Dr. Manoharan also serves as the chairman of the Department of Urology at Baptist Health South Florida and a professor of urology at Herbert Wertheim College of Medicine, Florida International University.Dr. Manoharan is a renowned leader in the treatment of prostate cancer, kidney cancer, bladder cancer and other urologic malignancies.
Dr. Manoharan’s research interests include stem cell applications, biomarkers and cancer outcomes. He serves as an editorial reviewer for several scientific publications. He is also widely published in peer-reviewed medical journals and is an invited speaker at national and international scientific symposiums. Dr. Manoharan has authored more than 140 scientific articles and 15 textbook chapters and has presented papers and posters at more than 100 national and international meetings. He served as vice chairman and a member of the International Bladder Cancer Guidelines committee, organized by the WHO and Société Internationale d’Urologie.
Dr. Andrew Scott Niekamp is a Vascular Interventional Radiologist with Radiology Associates of South Florida and joined the group in July of 2020. He currently practices at Baptist Hospital of Miami, South Miami Hospital and Doctors Hospital.
A native of Ohio, Dr. Niekamp received his undergraduate degree and medical degree from The Ohio State University. He then went on to complete his residency training in diagnostic radiology at the University of Texas at Houston/M.D. Anderson Cancer Center. Following residency, he completed a fellowship in Vascular and Interventional Radiology at the Miami Cardiac & Vascular Institute.
Dr. Niekamp’s interests are in the diagnosis, treatment and management of peripheral arterial disease, venous disease, aortic disease as well as hepatobiliary disease. He is active in clinical research and has published numerous papers encompassing many different aspects of interventional radiology. Dr. Niekamp is also an active member in the Society of Interventional Radiology and has given multiple research and educational podium presentations throughout both North America and Europe.
Dr. Malcolm M. Bilimoria is a general surgeon in Arlington Heights, Illinois and is affiliated with multiple hospitals in the area, including Amita Health Elk Grove Village and Amita Health Adventist Medical Center-Hinsdale. He received his medical degree from Northwestern University Feinberg School of Medicine and has been in practice for more than 20 years.
Dr. Rony Avritscher is an Associate Professor and co-chair of the pre-clinical research program in the Department of Interventional Radiology. Dr. Avritscher earned his medical degree from the University of Sao Paulo, in Sao Paulo, Brazil. He completed his radiology residency at the University of Texas Medical School at Houston and Interventional Radiology Fellowship at MD Anderson Cancer Center and subsequently joined the faculty in 2006. He is certified by the American Board of Radiology and holds a Certificate of Added Qualification in Interventional Radiology.
Prof. Dr. Tze Min Wah
MSc (Birmingham, UK), PhD (Leeds, UK)
MB ChB (Leeds, UK), FRCR (UK), CCST (UK), , EBIR (CIRSE), FHEA (UK), Pg. Cert. Clin. Ed. (Leeds, UK)
Honorary Professor and Consultant Radiologist
Clinical Lead for Interventional Oncology at Leeds Teaching Hospitals Trust (LTHT)
Interventional radiologist with specialist interest in both imaging and Interventional Oncology (IO) treatments. IO is the 4th pillar of cancer care alongside surgical, clinical and medical oncology. Since 2003, she has led and developed the IO programme at LTHT using various technologies e.g. radiofrequency (RFA), microwave ablation (MWA), cryoablation (CRYO) and irreversible electroporation (IRE) for a range of cancers such as liver, lung, renal, pancreas, adrenal, spleen etc. Today, Leeds is one of the leading national and international IO centres with reputable clinical outcomes and provides a full complement of innovative technologies such as RFA, MWA, CRYO and IRE for cancer treatment. She is one of the pioneers and leading interventional radiologists in the UK with a vast amount of clinical experience in renal ablative therapy. She has participated in grant funding research and lectured extensively on IO related topic to help to promote awareness and providing mentoring schemes to many trainees and consultants in IO on global platform since 2003.
In addition, she is a passionate champion for female leadership and love to inspire more women into Interventional Radiology. She has strived to inspire all male and female IRs to help in closing the IR gender gap issue. She is keen to share the publication on IR Gender Gap work that she has collaborated with CIRSE in 2017 and published in CVIR 2018 titled- The Interventional Radiology (IR) Gender Gap: A Prospective Online Survey by the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) and the publication can be downloaded at https://www.ncbi.nlm.nih.gov/pubmed/29789874.
Keith Quencer MD is an interventional radiologist at the University of Utah where he is an Assistant Professor and the associate section chief, fellowship director and the associate IR/DR program director. His main clinical focuses are renal ablation, adrenal vein sampling and IVC filter removal.
Constantino S. Peña, MD is an interventional radiologist at the Miami Cardiac and Vascular Institute at Baptist Hospital in Miami Florida where he also serves as the Medical Director of Vascular Imaging. Dr. Peña earned his B.S. and M.S. from the Stanford University Department of Biology in Palo Alto, Calif., prior to earning his medical degree from the Yale University School of Medicine in New Haven, Conn. He completed his residency in Diagnostic Radiology in 1999 as well as a Vascular and Interventional fellowship in 2000 at Massachusetts General Hospital in Boston, Mass. An educator, Dr. Peña is also a Clinical Assistant Professor of Radiology at the Florida International University College of Medicine in Miami as well as a Collaborative Associate Professor of Radiology at the University of South Florida College of Medicine in Tampa, Florida. He is on the Annual Meeting Committee of the SIR. He has served as the Chair of the Cardiovascular Radiology & Intervention Council of the American Heart Association (AHA) and a board member of the IAC CT. He has served on several committees for many professional organizations, including the RADInfo Committee of the ACR and RSNA, the Society of Interventional Radiology (SIR) IO service line, and the Vascular and Interventional Subcommittee Scientific Program Committee (SPC) for the Radiological Society of North America (RSNA). Dr. Peña is a fellow of the SIR, AHA, and SCCT.
Dr David M Liu MD is an Interventional Radiologist with the current appointments of Clinical Professor of Radiology at the University of British. He is board certified in both Canada and the US, and holds appointments at the Vancouver General Hospital, University of British Columbia Hospital and the BC Cancer Agency with a cross appointment in the department of Surgery.
Dr Liu received his medical degree from University of Toronto, completed his radiology residency at University of British Columbia, and interventional radiology fellowship at Northwestern Memorial Hospital, and has practiced on both sides of the border. In addition to benchside and clinical research in the fields of novel embolic platforms, ablative technologies and cancer related thromboembolic disease. Dr Liu maintains an active clinical practice interventional oncology practise incorporating all aspects of embolization, ablation, venous access, and palliative therapy in all organ systems.
He is the co-founder and co-chair of the Symposium HPB Oncology at Whister (SHOW). He has presented internationally, authored book chapters, and publications relating to minimally invasive locoregional cancer therapy. He holds specific interest in the treatment of hepatocellular carcinoma, and metastatic colorectal carcinoma and is actively involved in both translational research and clinical trials.
Nishita Kothary, MD, FSIR
Professor, Interventional Radiology
Stanford University Medical Center
Clinical and Research Focus
Technology and Innovation
Hepatocellular cancer genomics
Advanced imaging techniques
Edward Kim MD, FSIR is Professor of Radiology and Surgery at the Icahn School of Medicine at Mount Sinai, and is Director of Interventional Oncology in the Division of Interventional Radiology. His clinical research has focused on the field of minimally invasive procedures for treatment of cancer. Through interdisciplinary collaboration with the division of liver transplantation and surgical oncology, numerous publications have been generated related to radiofrequency ablation, microwave ablation, transarterial chemoembolization, radioembolization and electromagnetic tracking for image guidance for the treatment of primary and metastatic liver cancer. Edward Kim participates in multi-center industry sponsored trials that study the use of novel devices for the treatment of liver cancer.
Adeel Kaiser, M.D., is a board-certified radiation oncologist at Miami Cancer Institute. He has expertise in the treatment of a number of solid tumor malignancies, with a special focus on genitourinary and gastrointestinal cancers. He also has significant experience in proton therapy dating back to 2008, when he served as an assistant professor at Loma Linda University Medical Center, the first clinical proton therapy center in the United States. At Miami Cancer Institute, Dr. Kaiser aims to provide patients with a personalized, integrative strategy for their cancer treatment by incorporating complementary therapies with radiation treatment.
1994-1996 Georg-August-University of Göttingen
1996 University of Vienna, Austria
1996-2001 Ludwig-Maximilians-University of Munich (LMU)
1999 University of California San Francisco (UCSF)
01/2001- 03/2008 Resident, Department of Radiology, University of Munich; Germany; Prof. Dr. med. Dr. h. c. Maximilian F. Reiser
05/2007- 08/2007 Research Fellowship, Interventional Radiology, MD Anderson Cancer Center, Houston, Texas
04/2008- 12/2010 Section Chief of Angiography and Interventional Radiology; Department of Radiology, University of Munich; Germany
05/2010 Associate Professor of Radiology
01/2011- present Head, Department of Diagnostic and Interventional Radiology, Hospital Brothers of Charity, Munich
Radiofrequency ablation of primary and secondary liver tumors
Radiofrequency ablation of lung, kidney and soft tissue tumors
Radiofrequency of benign osseous tumors (Osteoidosteoma)
Vertebroplasty in osteoporotic vertebral fractures
Vertebroplasty / osteoplasty in tumoral osteolysis
Radioembolization of primary and secondary liver tumors
95 authorships in national and international peer reviewed journals
• 23 first-authorships
• 67 co-authorships
• 5 last-authorships
10 book chapters:
• 4 first-authorship
• 6 co-authorship
• European Radiology, “Most Cited Paper of Volume 12 (2002)”:
• ”Multislice helical CT of the heart with retrospective ECG gating: reduction of radiation exposure by ECG-controlled tube current modulation”
• ESGAR 2004: TOP 50 presenter
• ECR 2009: Winner of the “Rolf W. Günther Foundation for Radiological Science”
European Radiology (Eur Radiol)
Journal of Vascular and Interventional Radiology (JVIR)
Journal of CardioVascular and Interventional Radiology (CVIR)
Fortschritte auf dem Gebiet der Röntgenstrahlen und bildgebenden Verfahren (RöFo)
German Roentgen Ray Society
Dr Farah Gillan Irani, (MD, FRCR, FAMS) is Senior Consultant, and Deputy Head of the Department of Vascular and Interventional Radiologist at the Singapore General Hospital. She is also the Service Lead for IR at Sengkang General Hospital, Singapore.
After completing her basic Radiology training in India she obtained her fellowship training in Interventional Radiology in London UK and Toronto Canada. She practices the whole gamut of IR but has special interest in Interventional Oncology, hepato-biliary and Vascular IR.
Dr Irani is an active member of the local Radiology and Interventional Radiology community. In additional to her clinical practise, she is interested in Research and Education helping groom the future IRs of tomorrow.
Dr. Gervais completed her medical training at Tufts University School of Medicine and her residency in Diagnostic Radiology and fellowship in Abdominal Imaging and Intervention at the Massachusetts General Hospital. After a short stay in private practice, she returned to academics as a staff radiologist at Children’s Hospital Boston where her clinical focus was nonvascular interventional radiology. She returned to MGH in 1998 where she has served in numerours leedership positions including as Division Chief of Abdominal Imaging. She currently servers as Associate Chair for Clinical Compliance in the Department of Radiology at the Massachusetts General Hospital. Her research areas of interest include percutaneous tumor ablation, nonvascular abdominal interventional radiology, and imaging for response assessment of oncologic therapies. She is an internationally known expert on the topic of renal tumor ablation and has written and lectured extensively on that topic.
Afshin Gangi, M.D., Hospital of Strasbourg, Strasbourg, France
Dr. Afshin Gangi received his education in the International French School of Teheran, graduating in 1980. During the summer of 1980, he attended medical school at the University of Reims in France, receiving his Degree in 1987. He began his residency in Strasbourg in 1987, first in the intensive care unit and Pneumology where he became excited about imaging and moved to the imaging department. After his Residency in general radiology and Neuroradiology, he worked one year in Luxembourg with Professor R.F. Dondelinger in Interventional Radiology.
Dr. Gangi began his fellowship in Strasbourg in November 1991 in the department of Neuroradiology and MSK with special interest in percutaneous procedures. He performed his first vertebroplasty in 1989 during his residency and continued to develop image-guided procedures in interventional oncology, especially under CT-C arm fluoroscopy and MR guidance. In 1995, Dr. Gangi obtained his Ph.D. in Laser Physics in Strasbourg. During the same year, he was appointed Assistant Professor in the University Hospital of Strasbourg and he became a full Professor of Radiology in 2000. Since 2014, he is working in King’s college London for research in interventional oncology and HIFU as an invited Professor with Professor Andy Adam.
Prof Gangi holds numerous patents and is an author of more that 200 peer reviewed articles. He has more than 35 book chapters to his credit along with over 500 abstracts at numerous national and international conferences.
Currently, Dr. Gangi is the Chairman of Radiology and Nuclear medicine in the University Hospital and work in the department of Interventional Radiology, with a special interest in Interventional Oncology. He is actively involved in different international society and is the vice president of Cardiovascular and Interventional Radiological Society of Europe (CIRSE).
Dr. Brown is Interventional Radiology Section Chief and Professor of Radiology at the University of Utah and works at both the Huntsman Cancer Center and University Hospital. For 26 years she was an Attending Radiologist at Memorial Sloan Kettering Cancer Center, where she established a national as well as international reputation in the field of Interventional Oncology. She is a founding member of Society of Interventional Oncology and member of the Editorial Board of the Journal of HPB. Her primary clinical focus has been on hepatobiliary intervention, with particular interest in local/regional therapy for hepatocellular carcinoma (HCC). She is well known to be a proponent of using embolization with particles/microspheres alone as primary treatment for HCC and for secondary hypervascular liver tumors, including metastatic neuroendocrine tumor, as well as for benign lesions such as hepatic adenoma. Dr. Brown was the Primary Investigator on an NIH supported, prospective, randomized trial of trans-arterial treatment for HCC, the results of which were published in the Journal of Clinical Oncology in 2016. She has a special interest in biliary intervention and has been a strong advocate for percutaneous, rather than endoscopic, intervention with primary stent placement in cases of high bile duct obstruction. Dr. Brown led the weekly hepatobiliary disease management conference at MSKCC for years and continues to attend interdisciplinary conferences in her new position at the University of Utah in order to promote image guided intervention for patients with appropriate indications. Although Dr. Brown sees herself as a clinician educator, and considers sharing her experience with others at meetings, conferences and in the interventional suite as important for the exchange of ideas and the growth and development of the field, she sees her most important role as advocating for and taking care of patients at the University and Huntsman Cancer Center.
Chris Brace, PhD, is an Associate Professor in the Departments of Radiology and Biomedical Engineering, and serves as the Assistant Dean for Graduate Affairs in the College of Engineering at the University of Wisconsin — Madison. His expertise includes applications of elecromagnetics in medicine, microwave tissue heating, medical imaging, multiphysics simulation and translational medical device research. He has authored over 120 manuscripts and book chapters and regularly speaks at international conferences on these topics. He also holds over 20 patents and was a co-founder of NeuWave Medical. Dr. Brace is a senior member of the IEEE, and a member of the Biomedical Engineering Society and Americal Society for Engineering Education.
a.o. Univ.-Prof. Dr. med
Deputy Chairman Department of Radiology
Chief Division of Interventional Oncology / Microinvasive Therapy
Innsbruck Medical University
Academic career history:
Since 2020 Deputy Chairman Department of Radiology Innsbruck Medical University (Chair: E. Gizewski)
Since 2002 Chief Division of Interventional Oncology / Microinvasive Therapy at the Department of Radiology (Chairman: o.Univ.Prof. Dr. Werner Jaschke), Innsbruck Medical University
2002 Board Certification in „Diagnostic Radiology“
2002 Associate Professor of Radiology (Venia legendi)
1996- 2002 Resident in Radiology, University Hospital Innsbruck (Chairman: W. Jaschke)
1995 M.D.- University of Innsbruck, Medical School (A)
1992- 1995 Institute of Anatomy- University of Innsbruck (A)
1993 Prince Charles Hospital- Brisbane (AUS)
1990- 1991 Dissertation Institute of Pathology- University Hospital Innsbruck (A)
1989 Humana Hospital- West Palm Beach (USA)
1989- 1990 Institute of Histology and Embryology- University of Innsbruck (A)
Main research areas and previous research achievements:
Minimal invasive tumor therapy (Radiofrequency Ablation, Alcohol Instillation, Transarterial Chemoembolization, …)
Immobilization, Fixation, Motion artifacts
3D- Navigation, Computer- assisted Surgery, Computer- assisted Interventions, Frameless Stereotaxy, Computer -assisted stereotactic interventional brachytherapy, 3D- surgical planning
Targeting devices for Stereotaxy
Image Fusion: CT- MR- PET- SPECT- Ultrasound
Past research funding:
Österreichische Nationalbank ÖNB 12479: Entwicklung einer Ziel- und Pfadplanungs-Software für minimal-invasive 3 D-navigierte Punktionen EU 40000
MITIGATE FP7 (Nr. 602306) EU 372.800,00 (PI Prof Schönberg)
KM-HYPO, Visipaque- Study, GE Healthcare EU 20000 (PI Doz Widmann)
DOC Funds (FWF AUSTRIA) PhD Program: 2.7 M Euro (PI Prof. Gizwewski)
2005- Head of the Working Group “Technique and Innovation” from the Austrian Society of Radiology
2005- Advisory Board of “Archives of Orthopaedic and Trauma Surgery”
2014-2016 President of the Austrian Society of Interventional Radiology (ÖGIR)
Dr. Abi-Jaoudeh is an American and Canadian board-certified vascular and interventional radiologist at the University of California Irvine. Dr. Abi-Jaoudeh earned her medical degree from the University of Montreal and completed internship and residency at the University of Laval in Québec, Canada a fellowship in interventional radiology at the University of Virginia in Charlottesville, Va. She then joined National Institutes of Health where she was a principal and associate investigator on several human trials. She also completed multiple animal and translational studies. In 2015, Dr. Abi-Jaoudeh joined the University of California Irvine where she has grown the research program. In 2018, she became the director of Clinical research of the department of Radiology. She is principal investigator on multiple Phase I, II and III trials. In 2020, she became the section of IR at UCI.
Her clinical interests include minimally invasive image guided interventions, including but not limited to, vascular and non-vascular oncological interventions.
She has authored multiple manuscripts and submitted two patents related to imaging technology in the angiography suite. Her research interests include fusion and functional imaging during image guided procedures, innovative therapeutic methods to treat metastatic and primary liver disease. Her goal is to grow a translational research program to improve UCI patient care and outcome.
Dr Abi-Jaoudeh is a fellow of the Society of Interventional Radiology, a member of the Royal Canadian College of Radiology and associate editor of the Journal of Vascular and Interventional Radiology. She is also on the scientific committee of the Society of Interventional Radiology annual meeting and the SIR foundation board.
Dr Pierre De Marini is an interventional radiologist at the University Hospital of Strasbourg, France in the department of Pr Afshin Gangi. His research interests focus mainly on percutaneous ablative therapies, but his field of clinical interest covers a wide range of interventional procedure including endobiliary and endovascular treatments. He is also a member of the European Training Forum in the CIRSE which aims to promote interventional radiology among medical students.
After completing medical school at the University of Amsterdam he specialized in prostate cancer care through his PhD on focal therapy for localized prostate cancer with irreversible electroporation. He now combines clinical Urology at the Amsterdam UMC with a post doctorate research position at the Garvan Institute and St. Vincent’s Prostate Cancer Centre on various prostate cancer research lines involving multiparametric MRI, PSMA PET CT, immunology, focal therapy, robotic surgery and active surveillance.
Dr. Klevos is fellowship trained in both Breast Imaging and Interventional Radiology. She completed her Radiology residency and fellowships at the University of Miami. Upon the completion of her training, she served in an academic capacity as a faculty member at the University of Miami in Breast Imaging and as the Chief of Breast Interventional Oncology. She is double board certified by the American College of Radiology in Diagnostic Radiology and by the American Board of Internal Medicine.
She has authored and co-authored several peer reviewed journal articles in the fields of both Breast Imaging and Interventional Radiology. She is recognized for her published works in Image Guided Cryoablation of Breast Tumors, Breast Cancer, Treatment of metastatic colorectal cancer with DEBIRI and Irreversible electroporation (IRE) for pancreatic cancer. She is a graduate of the founding class of the PLA (Physician Leadership Academy-South Florida chapter) and has published articles on important topics like Physician Burnout and the ‘Business of Medicine’. Additionally, she has been an invited speaker in multiple national and international medical conferences in the fields of Breast Imaging and Interventional Radiology.
Her current research interest and passion is focused in the field of Breast Cancer and finding minimally invasive treatments to cure breast cancer including Cryoablation.
Assistant Professor of Radiology at Northwestern University Feinberg School of Medicine Chicago, IL
As an interventional radiologist, I use image guidance (x-rays, ultrasound, CT, PET, or MRI) to perform minimally invasive procedures. The images are used to direct tiny catheters, wires, and needles in order to diagnose and treat tumors. Using image guidance allows us to perform a wide variety of procedures without making large incisions, leading to shorter recovery times and fewer complications. We can also treat tumors by burning or freezing them (ablation) or clogging the arteries that supply them with different materials (embolization). Other procedures we perform include biopsies, opening an obstructed channel (for example, a vessel, a bile duct, or a ureter), or stopping a bleeding vessel.
I am also trained as a computational biologist, which means I develop, adapt, and apply algorithms from machine learning and information theory to biology. Some of my previous work focused on building mathematical models of biological networks such as gene networks and structural brain networks. Currently I am working on applying these same tools to analyzing genomic data from tumors to better predict and ultimately better tailor treatments to individual patients.
Dr. Bradford Wood directs a multi-disciplinary team (NIH Center for Interventional Oncology) that develops and translates devices, software, and navigation approaches for cancer patients via novel local and regional minimally-invasive image-guided therapies. Dr. Wood has directed the Interventional Radiology Research Lab from 2004 to present, and was Acting Co-Director of Radiology from 2006 to 2008. His research relies upon multi-disciplinary team science within multiple institutes and holds appointment in Radiology & Imaging Sciences in the CC, as well as the Urological Oncology Branch in NCI/CCR. He has received both the Clinical Center Director’s Award and the NIH Director’s Award, and has published widely in the field of Interventional Radiology and the emerging discipline in Interventional Oncology. The Center for Interventional Oncology translates technologies and paradigms for first in human treatments for cancer and cultivates interventional radiology applications within a muliti-disciplinary framework, to apply biomedical engineering to solve real-life clinical problems and patient care needs. His team’s achievements include helping to pioneer several technologies from concept to bench to patient, including prostate cancer MRI/TRUS fusion biopsy and ablation, image-able iodinated drug eluting beads for chemoembolization of liver tumors, heat deployed chemotherapy combined with thermal ablation for liver cancer, “medical GPS” electromagnetic (EM) tracking for fusion of ultrasound to CT, MR, and PET, and fusion for needle-based procedures like biopsy and thermal ablation, and other smart needles, devices, and software for minimally invasive, multi-modality, image-guided procedures. Dr. Wood &/or the CIO team performed “First-in-human” treatments including: First RFA for kidney tumors; First RFA of pheochromocytoma, adrenocortical carcinoma, & chordoma; First thermal ablation of liver tumors augmented with heat-deployed liposomal doxorubicin; First iodinated & image-able drug eluting bead embolization of liver tumors; First GPS-enabled ablation and biopsy devices; Ultrasound fusion enabled navigation systems; and PET, MRI, CT and ultrasound fusion interventions.
Clinical Interest for Patients I take care of patients with all kinds of bone and soft tissue tumors and cancers, including sarcomas, desmoid tumors, GIST, and PVNS (tenosynovial giant cell tumor). I an an expert not only in standard chemotherapy treatments, but also am active in clinical trials including immunotherapy, and personalized/precision medicine. Care Philosophy I believe that medicine, especially cancer medicine, is best practiced as a partnership between doctors, researchers, and patients. Decisions are always best made as a team effort, taking into account every aspect of a patient’s unique situation! Personal Interests I have recently moved from Miami, Florida to Denver and had to change my hobbies a bit! My husband and I love fishing and boating, and now are getting into exploring the incredible outdoor activities, including hiking, off-roading in our Jeep, learning to ski, and just being outside with our dog! Volunteer Activities I am active with several patient-initiated foundations as an advisory board member, helping to empower patients, families and advocates to advance research to find a cure for sarcomas. Public Speaking Yes I enjoy speaking to patients, families, and physicians in the community to raise awareness of sarcomas and to provide updates on new research including immunotherapy.
Interventional radiologist with interventional oncology as special field of expertise. Head fellowship and differentiation program interventional radiology for (resident) radiologists. Certified senior investigator interventional radiology and oncology trial reader. Primary investigator of several multicenter controlled studies in the field of thermal and non-thermal ablation and trans-arterial therapies for malignancies within the liver, pancreas and biliary tract. Expert in open and percutaneous minimally invasive image guided treatments such as radiofrequency ablation, microwave ablation, irreversible electroporation (nanoknife), transarterial bland embolization, chemo- and Y90 radioembolization. General expertise in treatment of vascular interventions such as acute traumatic and non-traumatic hemorrhages, peripheral arterial disease (PTA and stenting), venous interventions and non-vascular interventions such as percutaneous transhepatic cholangiography, abscess drainage, ultrasound and CT guided biopsy and percutaneous nephrostomy
Minesh P. Mehta, M.D. Medical School: University of Zambia, Zambia Post Graduate: Ndola Central Hospital, Zambia Radiation Oncology, University of Wisconsin Board Certifications: American Board of Radiology; United Council for Neurologic Subspecialties
Dr. McWilliams obtained his Bachelor of Science in Biology at Truman State University in Missouri, where he graduated valedictorian and Summa Cum Laude. He then attended the David Geffen School of Medicine at UCLA, where he received multiple letters of distinction and was selected for the Alpha Omega Alpha National Medical Honor Society. After completing a transitional internship at St. Vincent’s Hospital in New York City, Dr. McWilliams returned to UCLA for radiology residency. There he served as Chief Resident, and also received awards for Outstanding Radiology Resident and Outstanding Graduating Senior Resident. He then remained at UCLA for interventional radiology fellowship, at which time he also served as Chief Fellow. Upon completion of his fellowship, Dr. McWilliams accepted a faculty position in the interventional radiology department at UCLA. There he splits his time between angio/interventional procedures and cross-sectional interventional procedures, with a focus on HHT, interventional oncology, prostate embolization, vascular disease, dialysis work, and liver interventions.
Dr. David C. Madoff is Vice Chair for Academic Affairs and Professor of Radiology at Weill Cornell Medicinein NYC. Dr. Madoff earned his B.A. from Emory University and his M.D. from the University of Pittsburgh. He completed his internship in Internal Medicine and residency in Diagnostic Radiology at SUNY at Stony Brook. His fellowship training in IR was at MD Anderson Cancer Center. He was on faculty at MD Anderson Cancer Center for a decade before joining Weill Cornell in 2011. From January 2011 to November 2015, Dr. Madoff served as IR Division Chief. Dr. Madoff has a strong background in clinical care and has treated many patients with complex oncological problems. He is world-renowned for his work on preoperative portal vein embolization, a technique based on the liver’s ability to regenerate that has been used in patients with hepatobiliary cancer to increase the size of the anticipated liver remnant before surgery. Without this procedure, many patients with potentially resectable disease would not be eligible for curative resection. Dr. Madoff is a leader in academic IR and an invited speaker at numerous national and international meetings. He authored over 120 peer-reviewed articles, written more than 30 book chapters and served as co-editor of four textbooks. Dr. Madoff served as Deputy Editor for RADIOLOGY from 2012-2017 and Deputy Editor-in-Chief of JVIR from 2007-2010. Dr. Madoff currently serves on the editorial boards of Techniques in Vascular and Interventional Radiology, Seminars in Interventional Radiology, Cancer Biology & Medicine and European Radiology Experimental. Dr. Madoff is active in many major radiological societies including RSNA, ARRS, SIR and AUR and serves on the Board of Trustees of the ARRT. Based on his important contributions to the field, Dr. Madoff was elected Fellow of SIR in 2007, ACR in 2015 and CIRSE in 2017.
Robert John Lewandowski, MD is the Director of Interventional Oncology at Northwestern Memorial Hospital in Chicago, Illinois. He specializes in minimally invasive image-guided cancer therapies for primary and secondary hepatic malignancies.
Transplant Center at Carolinas Medical Center
1000 Blythe Blvd.
Charlotte, NC 28203
Get Directions | View Map
Jackson Memorial Hospital
Completion Year: 1999
Medical School or Graduate School
University of Miami School of Medicine
Completion Year: 1992
Specialty: General Surgery
Completion Year: 1997
American Board of Surgery
Fred T. Lee Jr, MD is a Professor of Radiology, Biomedical Engineering, and Urology, The Robert A. Turrel Professor of Imaging Science, and the Chief of Abdominal Intervention at the University of Wisconsin. Previous roles include Chief of Abdominal Imaging and Intervention and Senior Vice Chair at the University of Wisconsin Department of Radiology. He has been a University of Wisconsin faculty member since 1991, and was designated as a Radiologic Society of North America Scholar in 1996. Dr. Lee established the Tumor Ablation Laboratory at the University of Wisconsin in 1995, one of the first of its type in the world. His work has resulted in over 200 scientific publications, hundreds of scientific and business presentations, 20 book chapters, 24 inventions/patents, and substantial federal and industrial grant support. He is the recipient of more than 50 major honors and awards including multiple “Best Doctor” awards, the UW Health Presidential Physician Leadership Award, and the Grand Prize in the 2014 Wisconsin Governor’s Business Plan Competition. Dr. Lee is a founding member of the International Working Group on Tumor Ablation, and a founder of three venture-backed biotech start-up companies devoted to cancer treatment: Cellectar, Inc. (Madison, WI), NeuWave Medical Inc. (Madison, WI a member of the Ethicon and Johnson & Johnson family of companies), and Elucent Medical, Inc. (Minneapolis, MN). NeuWave Medical was sold to Ethicon (Johnson & Johnson) in May 2016, and Dr. Lee remains as a consultant. Dr. Lee currently serves on the board of directors and as Senior Medical Advisor for Histosonics, Inc., a University of Michigan startup company developing a non-invasive, non-thermal focused ultrasound technology for tissue destruction, and is a founder and board member of LiteRay LLC, a company developing methods to reduce radiation dose to physicians and patients during percutaneous interventions.
Maureen Kohi, M.D.
Chief, Interventional Radiology and Biomedical Imaging
505 Parnassus Ave., Room M-361
San Francisco, CA 94143
Phone: (415) 353-1300
Appointments: (415) 353-2573
Billing: (415) 514-8888
Fax: (415) 353-8570
Hours: Monday to Friday
8:30 a.m. – 5 p.m.
Radiology at Divisadero Street
1600 Divisadero St., Room A-142 and A-219
San Francisco, CA 94115
Scheduling: (415) 353-2573
CT, MRI and Bone Densitometry: (415) 885-7282
X-Ray and Nuclear Medicine:
Fax: (415) 353-7299
8 a.m. – 5 p.m.
Diagnostic Radiology, American Board of Radiology
More about Maureen Kohi
New York School of Medicine 2005
UCSF Medical Center 2010
UCSF Medical Center 2012
Selected Research and Publications
Seo Y, Khalighi MM, Wangerin KA, Deller TW, Wang YH, Jivan S, Kohi MP, Aggarwal R, Flavell RR, Behr SC, Evans MJ. Quantitative and Qualitative Improvement of Low-Count [68Ga]Citrate and [90Y]Microspheres PET Image Reconstructions Using Block Sequential Regularized Expectation Maximization Algorithm. Mol Imaging Biol. 2019 Apr 15.
Wang M, Ballah D, Wade A, Taylor AG, Rizzuto G, Li B, Lucero J, Chen LM, Kohi MP. Uterine Artery Embolization Following Cesarean Delivery but Prior to Hysterectomy in the Management of Patients with Invasive Placenta. J Vasc Interv Radiol. 2019 Mar 25.
Wang M, Laguna B, Koethe Y, Lehrman E, Kumar V, Kohi MP. Bridging the Gender Gap in the Society of IR: A Benchmark Study. J Vasc Interv Radiol. 2019 Feb 27.
Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.
Dr. Kim is an Associate Professor of Radiology at Georgetown University Medical Center where he serves as the Chief of the Division of Interventional Radiology. After receiving his medical training from Drexel University College of Medicine, Dr. Kim completed a surgical internship at Medstar Georgetown University Hospital. He went on to perform a research fellowship at Memorial Sloan Kettering Cancer Center where he studied various molecular pathways involved in cancer development. He performed his post-graduate training in radiology at Medstar Georgetown University Hospital where he also completed his fellowship in Vascular and Interventional Radiology. His main clinical and research interest is in interventional oncology – specifically to develop methods to augment outcomes from liver-directed therapies – and has published a number of papers on this topic. He currently serves as an investigator in a number of single center and multi-center trials in various interventional oncology treatments.
Dr. Geronemus received his undergraduate degree from Indiana University and his medical degree from the University of South Florida College of Medicine in Tampa, Florida. He completed a residency in diagnostic radiology at the University of South Florida College of Medicine, as well as a fellowship in interventional radiology at Miami Cardiac & Vascular Institute.
Dr. Geronemus is Board-Certified in Diagnostic Radiology with a Certificate of Added Qualification in vascular and interventional radiology.
Dr. Christopher Gomez is a specialist in urinary incontinence and urogenital reconstruction. He earned his medical degree and completed a residency in urology at the University of Miami where he was recognized for his accomplishments in urologic research. He went on to complete a fellowship in female urology, urodynamics and reconstruction. He returned to the University of Miami in 2011 at which point he became a faculty member with the urology department, and in 2012, he became the associate program director of the urology residency program. In 2018 he joined the Miami Cancer Institute to start a center for Continence and Genitourinary Reconstruction. Dr. Gomez was awarded the American Urological Associate/Urologic Society of India academic exchange scholar grant where he focused on urogenital reconstruction in India. He was also selected by the Society of Genitourinary Reconstructive Surgeons and American Urological Society to participate in urethral reconstruction and vesicovaginal fistula repairs in Haiti. He continues to lecture nationally and internationally regarding the impact of neurologic disease on the urinary system and urogenital reconstruction. Dr. Gomez is currently working to advance urologic medicine using minimally invasive surgical techniques to treat benign prostatic hyperplasia, pelvic organ prolapse and urinary incontinence, and he is actively involved in research to test and develop new treatments for these disorders.
Chiara Floridi, MD San paolo University Hospital Milano Born 05.05.1982 M.D., Univeristy of Perugia (110/110 cum laude), 2007 MEDICAL TRAINING Residency in Diagnostic and Interventional Radiology, University of Perugia , 2008-2012 Fellowship in Interventional Radiology Univerity of Insubria-Varese, 2012-2013 PROFESSIONAL EXPERIENCES Physician Consultant at Diagnostic and Interventional Radiology Varese Hospital (2013-2016) Physician Consultant at Diagnostic and Interventional Radiology san Paolo University Hospital, Milano (2016-Present)
Mehul Harshad Doshi, MD, is an Interventional Radiologist at Cleveland Clinic Florida, Weston, and a Clinical Affiliate Associate Professor of Radiology at Charles E. Schmidt College of Medicine – Florida Atlantic University. Dr. Doshi completed his medical school and residency in Radiology from B. J. Medical College, civil hospital, Ahmedabad (India) in 2004. He subsequently completed fellowships in Vascular Interventional Radiology and Neuroradiology from Jackson Memorial Hospital/ University of Miami in 2008. He served as a faculty in the Department of Radiology and Interventional Radiology at the University of Miami from 2008 to 2018. In April 2018, Dr. Doshi joined the section of Interventional Radiology at Cleveland Clinic Florida. Dr. Doshi is Board-Certified in Diagnostic radiology with a Certificate of Added Qualification in Vascular and Interventional Radiology from the American Board of Radiology (ABR). He is a member of the Society of Interventional Radiology (SIR). Dr. Doshi’s areas of clinical interest include Interventional Oncology, TIPS and management of portal hypertension, embolization and ICV filters. His research interests include tissue ablation, chemoembolization, portal hypertension and IVC filters.
Dr. Thierry Jacques de BAERE 20 juillet 1962 French Head of department of intreventional radiology Institut Gustave Roussy, 39 rue Camille Desmoulins, Villejuif, France – Tel : 00 33 142115428 Main interests : Tumor ablation Portal vein embolization Intra-arterial therapies Digestive tract intervention Chairman of standard of practice committee at CIRSE 2007-2009 Member of the scientific committee of WCIO 2006-2008/2011, ECIO 2008/2010, CIRSE 2008/2009, GUEST 2008-2011, ECR 2013 Chairmann of the proram committee ECIO 2012/2013 Memeber of the CIRSE Foundation Advisory Council 2008-2012 Reviewer JVIR, CVIR, Radiology, European Radiology Full time dedicated to interventional oncology at Institut Gustave Roussy since 1991. Clinical work dedicated to minimal invasive therapy for treatment of liver, lung and kidney tumors. Treatment of liver tumor is optimized due to excellent collaboration with surgery and medical oncology teams, namely through devellopement of many synergistic treatment, including optimization of various intra-arterial therapies for primary and secondary liver tumors. We have been working since over 15 years in the field of percutaneous ablation of liver tumors either by direct injection, or more recently physical destruction . Our first RF experience was in 1996. We are also investigated pre-operative portal vein embolization in order to hypertrophy unembolized parts of the liver. These treatments have been develloped from experimental studies in order to allow a rapid transfer from bench-top to clinical applications.
Michael Darcy, M.D., Professor of Radiology at Washington University in St. Louis Chief, Interventional Radiology at Barnes Jewish Hospital and the Mallinckrodt Institute of Radiology
Dania Cioni MD Assistant Professor of Radiology at Department of Radiology, Univerity of Pisa Clinical and research activities on diffuse and focal liver lesions buy using contrast ultrasound, computed tomograpy and magnetic resonace imaging, and on interventional oncology procedures and new molecular-targed drug for the treatment of liver malignancies
Jacob Cynamon, MD, Director of Vascular and Interventional Radiology at Montefiore Medical Center and Prof of Radiology at Albert Einstein College of Medicine. Chairman of the AIMsymposium, an annual vascular and interventional radiology symposium held in November in NYC. Currently planning the 27 th year. Research in Dialysis access, Arterial and venous thrombolysis. PI for the Safeflow IVC filter. Seatlle 2 investigator. Recently described a new technique for transvenous liver biopsies- TransFemoral TransCaval (TFTC) liver biopsies One of the team that performed the first Aortic Stent Graft procedure in the US. Current practice is concentrated on interventional oncology, Venous Disease, Women’s health, and Prostate Artery Embolization for BPH.
Undergraduate: University of Miami, School of Engineering Medical School: University of Miami, School of Medicine Residency: Emory University Affiliated Hospitals Fellowship: Cardiovascular and Interventional Radiology at Hospital University Pennsylvania and Children’s Hospital of Philadelphia Board Certification: American Board of Radiology Societies: Radiological Society of North America, Society of Interventional Radiology Specialties: Interventional Radiology with CAQ Dr. Cohn joined Radiology Associates of Hollywood in 1999 after completing his fellowship training from the Hospital at University of Pennsylvania and Children’s Hospital of Philadelphia. His particular area of expertise is in interventional oncology services. Dr. Cohn has pioneered and is responsible for bringing various new interventional oncological procedures to Memorial and south Florida such as: Hepatic Arterial Chemoembolization, Radio-embolization and Radio Frequency/Microwave/Cryo Ablation for oncology patients. He is highly experienced and trains other physicians throughout the U.S.in interventional oncological intervention such as radio-embolization. Dr. Cohn frequently travels as an invited lecturer throughout the United States and has also published several articles. He now serves as Co-Director of Interventional Radiology at the Memorial Healthcare System, Broward County Florida and is an assistant Professor at the Florida Atlantic University Medical School.
Dr. Michael Chuong, MD is a radiation oncologist and director of radiation oncology clinical research at Miami Cancer Institute. He is a member of the NRG Oncology GI committee and the Disease Site Committee Chair for the Proton Collaborative Group. His clinical practice focuses on gastrointestinal cancers for which he has expertise in treating with IMRT, MR-guided SBRT, and proton therapy. He has published numerous peer reviewed manuscripts and is actively involved in clinical trials development.
Dr. Chapiro joined the Department of Radiology and Biomedical Imaging as a research scientist and interventional radiology resident from Berlin, Germany. After graduating from the University of Leipzig and upon completion of his research thesis at the Justus-Liebig University in Giessen, he served as a postdoctoral fellow in interventional oncology at The Johns Hopkins Hospital and then as radiology resident at the Department of Radiology, Charité University Hospital in Berlin. Dr. Chapiro works on the development of novel imaging biomarkers, tumor response criteria, staging systems and molecular imaging techniques for image-guided liver cancer therapies. His translational research portfolio includes the development of novel embolic agents as well as the application of artificial intelligence and machine learning solutions for the assessment of liver cancer. His basic research interest mainly focuses on tumor metabolism and immuno-oncology. With over 50 peer-reviewed publications, book chapters and news articles, Dr. Chapiro advocates the element of personalized medicine in interventional oncology, which is the most rapidly growing field in interventional radiology practice. Creating innovative and clinically practicable solutions and translating them from concept to practice has been his central mission for the past five years. He is the co-initiator of the “Rising Star” Student Exchange Program in collaboration with the Charité University Hospital in Berlin and co-directs the Yale Radiology Research laboratory.
Dr. Jorge Raul Caso is an adjunct assistant professor of urology at FIU and the director of the urologic oncology fellowship and of the kidney cancer institute at the Miami Cancer Institute at Baptist Health. He has lectured in national and international conferences on advanced laparoscopic and robotic surgery for genitourinary malignancies. Dr. Caso has extensive experience in kidney surgery, including the utilization of laparoscopic single site and robotic platforms for nephrectomy and partial nephrectomy. He has particular interest in extraperitoneal and retroperitoneal approaches to renal and pelvic surgery, bypassing intraabdominal approaches where precluded by medical history. He is an expert in performing robotic radical prostatectomy and complex upper and lower tract reconstruction by minimally invasive means. Dr. Caso has published extensively in the surgery and natural history of varied malignancies. His interests include outcomes based-research and novel surgical techniques.
Theresa Caridi, M.D., is an assistant professor in the Division of Vascular and Interventional Radiology at MedStar Georgetown University Hospital in Washington, D.C. After attending the University of Florida for medical school and radiology residency, Dr. Caridi completed a fellowship in vascular and interventional radiology at the University of Pennsylvania. She then joined the faculty at Georgetown. Dr. Caridi is board certified in radiology and also holds her specialty certification for interventional radiology. She currently serves as the medical student clerkship director for interventional radiology at MedStar Georgetown University Hospital. Dr. Caridi is an active member of the Society of Interventional Radiology (SIR) and is presently serving as an officer on the SIR Foundation Board of Directors as the Development Division Chair. She has been named a Washingtonian Top Doctor in 2018, an honor given to her as a preeminent physician in the DC, Maryland and Virginia region. Special interests include the treatment of uterine fibroids and other uterine conditions, pelvic venous congestion/ varicocele, prostate hypertrophy, and pulmonary AVMs.
Jim Caridi MD FSIR, Professor of Vascular and Interventional Radiology and Chairman of Radilogy at Tulane University Medical School. Initial training began at FSU and UF in Florida where he was chief of vascular and interventional radiology for 20 years. Part of this time he also served as fellowship program director. During his tenure along with Dr. I Hawkins and staff they published many peer reviewed articles as well as book chapters and posters. Many of the educational materials centered around improving safety and techniques for vascular and interventional procedures as well being the thought leaders for the use of CO2 as an alternative contrast agent. In 2013 Jim moved to Tulane University Medical Center where he started as an attending in VIR. He has since become Chairman of the Department of Radiology.
James F. Benenati, MD, FSIR, is a practicing Interventional Radiologist, Medical Director, Noninvasive Vascular Laboratory and Fellowship Program Director at the Miami Cardiac & Vascular Institute at Baptist Hospital in Miami, Florida.
He is a Clinical Professor of Radiology at Florida International University College of Medicine and Associate Professor of Radiology at the University of South Florida College of Medicine. He is past President of SIR. He served as President of the Vascular Division for the Intersocietal Accreditation Committee (IAC) and served for over a decade on their board. He served as the annual meeting chairman for SIR in 2005. He was the recipient of the SIR Charles T. Dotter Award in 2014.
He has participated in numerous clinical research projects and national trials. His interest include peripheral arterial disease, abdominal aortic aneurysm and management of pulmonary embolism. He has authored and co-authored more than 100 scientific publications. He has been a Program Director of ISET for over 20 years.
He attended the University of Notre Dame as an undergraduate, received his medical degree from the University of South Florida College of Medicine, completed a residency in Diagnostic Radiology at Indiana University and a fellowship at Johns Hopkins.
Dr. Daniel Brown is a radiologist in Nashville, Tennessee. He received his medical degree from Drexel University College of Medicine and has been in practice for more than 20 years.
Dr. Sandeep Bagla is board certified in Diagnostic Radiology with a Certificate of Added Qualification in Interventional Radiology. He graduated with honors from St. Georges University School of Medicine before completing residency in Diagnostic Radiology at Albany Medical Center where he also served as Chief Resident. Dr. Bagla completed subspecialty training in Vascular & Interventional Radiology at George Washington and completed his Certificate of Added Qualification (CAQ) in Vascular & Interventional Radiology. He has been selected as a Top Doctor in multiple publications, including Washingtonian Magazine. Dr. Bagla is actively involved in clinical research, leading multiple clinical trials and receiving national grant awards. His research interests have included: Prostate Artery Embolization in the Treatment of Benign Prostate Hypertrophy, Soft Tissue Tumor Ablation, Pancreatic Cancer and Pulmonary embolism. He has delivered invited lectures at numerous scientific meetings both nationally and abroad. Dr. Bagla has numerous publications in peer- reviewed journals and currently reviews manuscripts for publication in two major medical journals: Journal of Vascular & Interventional Radiology and Cardiovascular & Interventional Radiology. He has co-authored book chapters on Prostate Artery Embolization and has delivered numerous invited lectures at national and international meetings. Dr. Bagla currently sits on the physician advisory board of multiple worldwide medical device companies providing his advice for the future of cancer and robotic therapy.
Dr. Horacio Asbun is a general surgeon in Kendall, Florida. He received his medical degree from University of Chile and has been in practice for more than 20 years. Dr. Asbun accepts several types of health insurance, listed below.
Angie Amaro PA-C has been in the field of Intervention Radiology for the last 5 years and is the Chief Physician Assistant of Interventional and Vascular Radiology at Miami Cardiac and Vascular Institute.
I am a Thoracic Medical Oncologist at the Miami Cancer Institute. Board Certified. Member of ASCO and IASLC. Have a special intrest in the treatment of lung cancer.
Board-certified medical oncologist who treats patients with gastrointestinal cancers. Specializing in primary liver cancer (hepatocellular carcinoma), pancreas, gallbladder, and bile duct tumors. As part of a multidisciplinary group, my colleagues and I offer patients a team approach to treating these cancers.
Govindarajan Narayanan, M.D., is an interventional radiologist at the Miami Cardiac & Vascular Institute and the Chief of Interventional Oncology at the Miami Cancer Institute, part of Baptist Health South Florida. He is Board certified in diagnostic radiology and holds a Certificate of Added Qualification in interventional radiology.
Dr. Narayanan received his medical training at Madras Medical College in India. He completed a residency in Nuclear medicine at Methodist Hospital of Brooklyn and Memorial Sloan Kettering Cancer Center in New York, as well as a residency in Diagnostic Radiology at St. Barnabas Medical Center in Livingston, New Jersey. He also completed fellowships in Interventional radiology at Medical University of South Carolina in Charleston and Stony Brook University Hospital in New York.
Most recently, he served as the Chief of Interventional Radiology at University of Miami and Jackson Memorial hospital, and as the founding Chairman of the Department of Interventional Radiology at the University of Miami Miller School Of Medicine, where he also served as a Professor of Interventional Radiology.
Dr. Narayanan’s primary clinical research interests include pancreatic, liver and colon cancer. A member of numerous professional and honorary organizations, he is also a pioneer in his field, developing the technique of percutaneous irreversible electroporation (IRE) of the pancreas. He is widely published in high-impact medical journals as Cancer, Journal of Vascular and Interventional Radiology and Cardiovascular and Interventional Radiology and serves as a reviewer and editor for several scientific publications. He has authored textbook chapters and is an invited faculty member and speaker at several national and international scientific meetings.
Riccardo Lencioni, MD, FSIR, EBIR, is Professor of Radiology at the University of Pisa School of Medicine in Pisa, Italy, and Honorary Research Professor of Interventional Oncology at the Miami Cancer Institute in Miami, USA. He was previously Professor of Radiology and Director of Interventional Oncology Research at the University of Miami School of Medicine. Professor Lencioni is one of the world’s foremost interventional oncology specialists, known especially for his highly influential work in liver cancer. He has been the principal investigator of several large, multicenter, randomized clinical trials investigating the use of image-guided interventions for the treatment of hepatocellular carcinoma and the potential synergies between loco-regional therapies and systemic agents. Professor Lencioni has been a leading member of several expert panels developing recommendations for research and clinical management of hepatocellular carcinoma.
He is also known for having developed modified RECIST criteria for the assessment of tumor response in hepatocellular carcinoma. Riccardo Lencioni has been the Founding Chairman of the European Conference of Interventional Oncology, a co-Founder and Chairman of the World Conference of Interventional Oncology, and a Founding Governing Board Member and Executive Secretary of the International Liver Cancer Association. Riccardo Lencioni has published 206 articles in peer-reviewed international journals indexed in PubMed and numerous chapters in textbooks of interventional radiology, gastroenterology, oncology and surgery. In addition, he has been the editor of nine books. According to the SCOPUS database, citations of his publications currently number in excess of 21,000, for an h-index of 60. Riccardo Lencioni has received numerous international awards for his research and has been an invited or honorary lecturer at more than 500 international meetings or conferences held in 65 different countries.